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C
hapter 1 
Introduction 
PREFACE 
Defaecation disorders are difficult to treat and cause serious impairment 
of quality of life in affected patients.1 Defaecation disorders can be 
classified in faecal incontinence and constipation. The different entities 
and their treatment are described here. 
FAECAL INCONTINENCE 
Faecal incontinence is defined as recurrent involuntary passage of faecal 
material or flatus through the anal canal.2 There are different scales to 
describe faecal incontinence, which correlate well with the clinical 
impression of severity. They serve as a useful instrument to compare 
patients and treatment modalities. The classification of faecal 
incontinence by Parks is often used and is pragmatic (Table 1.1).3 The 
classification of Williams is a five point scale, containing the same items 
as the Parks’ scale adding grade 5; always incontinence for solid faeces, 
grade 4 means always incontinence for liquid faeces, sometimes 
incontinence for solid faeces.4 The classification of Vaizey is more 
precise and includes the social impact of the disorder (Table 1.2).5  
 
 
Table 1.1 Grading faecal incontinence according to Parks.3 
Grade 1 Continent 
Grade 2 Incontinent of flatus 
Grade 3 Incontinent of liquid stool 
Grade 4 Incontinent of solid stool 
 
 
The prevalence of faecal incontinence for solid stools is estimated to be 
1.4-5% and up to 19.6% of the population is incontinent for flatus, liquid 
stools or solid stool.2,6,7 The prevalence of faecal incontinence increases 
with age.8 However, due to the underreporting of symptoms by patients, 
different standardized scoring scales, differences in data collection and 
variations in the selected populations, true prevalence remains unknown 
and is hard to establish.9 
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Table 1.2 Faecal incontinence score according to Vaizey (minimum score 0; maximum score 
24).5 
Incontinent Never Seldom Sometimes Regular Daily 
Solid stool 0 1 2 3 4 
Liquid stool 0 1 2 3 4 
Flatus 0 1 2 3 4 
Change lifestyle 0 1 2 3 4 
Never, not in the past four weeks; seldom, once in the past four weeks; sometimes, > once in the 
past four weeks but < once a week; regular, several times a week; daily, one or more times a day 
 
 No Yes 
Use of sanitary napkins 0 2 
Use of constipating medication 0 2 
Impossible to postpone defecation 15 minutes 0 4 
 
 
Continence is the result of coordinated activity of the rectum and anal 
sphincters.10 This is determined by many factors. Consistency and 
volume of stool is important. The most common causes of faecal 
incontinence are diarrhoea or constipation with overflow incontinence, 
especially in children and elderly people.11 Diarrhoea can be caused by 
certain medication, after colon resection, proctitis or secondary overflow 
diarrhoea as result of faecal impaction. In case of diarrhoea, this has to be 
treated first by diet or medication. The majority of patients can be 
diagnosed and treatment initiated in the primary care setting when the 
physician is well informed about treatment options. Patients who fail to 
respond within a few weeks need to be referred.11 Then other causes of 
diarrhoea have to be excluded.12 Other treatments for faecal incontinence 
will not succeed in case of diarrhoea. Pelvic floor, anal sphincters, anal 
and rectal sensitivity, rectal capacity or compliance are other important 
factors influencing continence.10 The most common aetiology of 
incontinence disorders is traumatic childbirth. This can cause a sphincter 
rupture with or without pudendal neuropathy.13,14 Anal surgical 
procedures, like treatment of perianal fistulas, fissures and haemorrhoids, 
can cause anal sphincter defects and are a common aetiological factor for 
incontinence.15 Decreased anorectal function is influencing faecal 
continence and can become apparent with increasing age, spinal cord 
injury, after abdominoperineal resection and in congenital disorders, like 
anorectal malformations or spina bifida.16-20 Substantial numbers of 
patients suffer from idiopathic faecal incontinence, in which the 
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aetiology cannot be identified. Table 1.3 shows the different aetiologies 
and their distribution in a study group of 200 patients with faecal 
incontinence in an university hospital.21 The study population has a 
selection bias, because these patients were tertiary referrals for a dynamic 
graciloplasty.  
Patients with complaints of faecal incontinence have to be evaluated to 
assess the grade and aetiology of incontinence. Besides this evaluation, a 
good medical history and physical examination, including rectovaginal 
examination, are very important.22 Recommended anorectal 
physiological tests that can be performed are anorectal manometry, rectal 
sensitivity and capacity tests and endo-anal ultrasonography.22-26 
Pudendal nerve terminal motor latency time measurements and 
defaecography can provide additional information.26 The clinical 
relevance of these individual anorectal tests is not always evident, but the 
potential strength comes from combining test results.27 Other 
investigations like a sigmoidoscopy or colonic transit time are performed 
when indicated, e.g. when a tumour, proctitis, or overflow incontinence is 
suspected.28,29  
 
 
Table 1.3 Aetiologies of faecal incontinence and their prevalences.21 
Aetiology Prevalence 
Anal trauma/rupture/fistula   49% 
Neurogenic     8% 
Congenital   14% 
Idiopathic   29% 
Total 100% 
TREATMENT OF FAECAL INCONTINENCE 
Conservative 
Treatment of faecal incontinence is difficult. The first choice is 
conservative therapy: medication and diet modifications to reduce 
colonic motility (loperamide, codeine phosphate, diphenoxylate and bile 
acid binders) or extraction of fluids from the luminal content (fibres). In 
case of overflow incontinence, medications, diet modification and bowel 
habit training to improve colonic motility have to be performed, which is 
successful in 60%.11 Pelvic Floor Rehabilitation (PFR)30 is pelvic floor 
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muscle training combined with biofeedback therapy31 and sometimes 
with electrical stimulation.32 Studies investigating treatment with PFR 
show different success rates. Most patient groups investigated in these 
studies however are not very large and only a few studies give a long-
term follow-up. These studies are difficult to compare because of the 
difference in investigational methods and follow-up.31,33-35 It is thought 
that patients with weakness of the external sphincter due to injury of the 
pudendal nerve or impaired rectal sensation caused by injury to the 
afferent nerve pathway, are most amenable to treatment with 
biofeedback.36  
Anal plugs can be used, giving satisfactory results for some patients, but 
pelvic floor function is needed to support the plug. Local side-effects like 
anal irritation, leakage and plug loss prevent its daily use.37 Since the 
presence of the plug itself causes a desire to defaecate, the ideal 
indication is a patient with a loss of sensibility. 
Retrograde colonic irrigation (RCI) can be considered when other 
conservative measures are  unsuccessful.38,39 Irrigation causes massive 
defaecation of liquid combined with faeces. When the bowel is empty no 
loss can be expected until new arrival of stool. This will normally take 
another day. During this time the patient is pseudocontinent. RCI was 
already performed in the past, but often forgotten in modern times. 
Surgery 
The surgeon can make the decision to perform a surgical procedure after 
failed conservative treatment, but the indications are often overlapping. 
The end-point of surgery should be recovery of faecal continence and the 
associated quality of life at the price of minimal morbidity and 
mortality.40 The surgical treatment in faecal incontinence gives an overall 
success in about 50-84%.30,41-51 
The postanal repair was introduced by Parks in 1975. An intersphincteric 
approach was used to sharpen the anorectal angle and thus improve 
continence in up to 81%.3 A more recent study suggested that there is an 
immediate benefit of postanal repair, but only 35% profit from a long-
term improvement. They recommend that the postanal repair should be 
offered to selected patients with persistent, severe faecal incontinence 
despite an anatomically intact external anal sphincter who are not 
candidates for or refuse all other operative modalities.52  
The total pelvic repair described by Deen and colleagues in 1993 is a 
combination of postanal repair and pre-anal levatorplasty.53,54 The 
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rectopexy or the Delorme procedure are performed in case of rectal 
prolapse with respect to faecal incontinence, which is successful in 38-
69%.55,56 In patients with defective anal sphincters an anal repair can be 
performed. A good sphincter repair produces good results in 70-80% of 
patients in the short-term.47,57,58 The outcome is similar whether direct 
end-to-end or overlapping repair of a sphincter defect is performed.58 In 
the medium term, deterioration of the continence following sphincter 
repair occurs; only a few patients are able to maintain full continence and 
only 50-75% are having improved continence.59-62 
The Sacral Nerve Modulation (SNM) is another procedure that is 
successful in patients with a structurally intact external anal sphincter in 
about 55-100% (Figure 1.1).30,41-46 Electrical stimulation of the sacral 
nerves has already been used successfully in the treatment of urinary 
incontinence by Tanagho et al. in 1988.63 The use of SNM in patients 
with faecal incontinence was first reported by Matzel and colleagues in 
1995.64 In SNM the nerves and reflexes are probably modulated to 
provide for example better rectal sensitivity,30 but the precise working 
mechanism has yet to be elucidated. SNM is nowadays also used in 
patients with limited external sphincter defects45,65 and in patients with 
constipation.1 A new percutaneous technique, insertion of a tined lead, is 
becoming more widely available and allows the implantation to be 
performed under local anaesthesia.66 
In case of a small sphincter defect (33% of the circumference) a SNM 
can be attempted.65,67 
 
 
 
 
 
 
 
 
 
Figure 1.1   Sacral Nerve Modulation. 
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When a sphincter repair gives insufficient results in large external 
sphincter defects, a second repair can be undertaken. When this second 
repair fails, SNM can be performed in functional failures, and a 
replacement of the sphincter has to be performed in structural failures.  
Mainly two techniques are available to treat patients with complete 
destruction of the sphincter complex or when other surgical techniques 
failed. The non-stimulated gracilis transposition was described first by 
Pickrell et al. in 1952.68 Techniques like the non-stimulated gracilo- and 
gluteoplasty are seldom used nowadays, because there is early fatigue of 
the muscles.69,70 
The dynamic graciloplasty (DGP) (Figure 1.2) and the artificial bowel 
sphincter (ABS) are the favoured sphincter replacement procedures in 
case of failing sphincters.13,18,21,71-79 Baeten and Williams and colleagues 
performed the first stimulated graciloplasties in 1991.4,80 The results of 
DGP are reasonable and even after longer follow-up the success rate is 
59%.81 Complications of the DGP are infection, constipation and pain. 
Most of the time these complications can be treated successfully.71,82,83  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2   Dynamic graciloplasty. 
 
 
The ABS is a modification of the artificial urinary sphincter especially 
designed for treatment of faecal incontinence by Lehur and Wong and 
colleagues.75,84,85 The prosthesis is composed of three components which 
are implanted: 1. an inflatable, occlusive cuff; 2. a pressure regulating 
balloon and 3. a control pump (Figure 1.3).75 The inflatable cuff is 
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brought around the anal canal and is connected to the control pump 
placed in the large labia in women or in the scrotum in men. This pump 
is connected to the pressure-regulating balloon that is positioned in 
Retzius’ space, dorsal of the pubic bone and ventral of the bladder. The 
different components are connected by subcutaneous tubes. A review 
reports a mean success rate of ABS of 45%, but results seem to 
deteriorate with time.81 The technical failure rate of the ABS is high and 
constipation can be a difficult problem.86 The biggest risk of the ABS is 
infection around the peri-anal cuff; this risk is about 17-25%.73,75,84,86,87 
The new transvaginal approach may reduce the infectious complications, 
however follow-up for this method is short.88 
The results of ABS seems comparable with the DGP in the short-term, 
but the ABS has a higher adverse event rate compared to the DGP and 
the results of ABS seem to deteriorate with time.79,81 However, different 
studies vary in methods and patient population, so it is preliminary to 
draw definitive conclusions.81 Therefore, it is difficult to give an advice 
in favour of one of the sphincter replacement techniques. In case of a 
short perineal length, it seems better to perform a DGP to prevent erosion 
of the cuff in the ABS procedure.86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3   Artificial Bowel Sphincter 
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Additional RCI can be started when the results of surgery are not 
satisfactory.38 When RCI is insufficient, antegrade irrigation can be 
performed usually by the Malone antegrade colonic enema (MACE) first 
described by Malone et al.89 In this procedure the appendix is pulled 
through the abdominal wall and serves as a colonic access for the 
irrigation tube. In patients with a previous appendectomy the terminal 
part of the ileum can be used.90 The distal side is pulled through the 
abdominal wall to serve as the irrigation stoma, and the proximal side is 
anastomosed to the ascending colon in an intussuscepted way. An urinary 
catheter is placed in the stoma and antegrade colonic irrigation is started. 
The most common complication is stenosis of the stoma caused by 
fibrosis, which can be treated by dilatations,89-92 and leakage of the 
irrigation fluid and faeces through the appendicostomy93 requiring 
surgical revision. Antegrade colonic irrigation can also be performed by a 
sigmoidostomy.94 
The final treatment option in severe faecal incontinence is an end-
colostomy. This can be a good alternative for intractable faecal 
incontinence. The quality of life can improve significantly for these 
patients.95,96 However, a small group of patients cannot adapt to the 
colostomy and dislike it intensely.96 
CONSTIPATION 
Constipation can be described by different objective criteria: infrequent 
defaecation less than three times a week, straining during defaecation or 
a feeling of incomplete evacuation after defaecation.97,98 Other symptoms 
that can be present are abdominal pain and bloating. The Wexner 
constipation score is a common score ranging from 0 to 30 to assess the 
severity of constipation in patients and success of treatment 
(Table 1.4).99 The Rome II Committee on Functional Gastrointestinal 
Disorders set forth criteria for the diagnosis of chronic constipation in 
1999 (Table 1.5).100  
Constipation affects 3-20.3% of the general population.101-103  
Defaecation is based on the coordination between colon, rectum, pelvic 
floor and anal sphincters. When this coordination fails constipation can 
develop. Constipation is caused by various factors. The Rome II criteria 
may permit the classification of chronic constipation into one of three 
subtypes: colonic inertia (delayed motility), outlet obstruction, and 
functional constipation.100 Slow transit constipation (colonic inertia) can  
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Table 1.4 Wexner constipation score (minimum score 0; maximum score 30).99 
Score 0 1 2 3 4 
Freq. of bowel 
movement 
1-2 times/   
1-2 days 
2x/week 1x/week <1x/week <1x/month 
Straining Never Rarely Sometimes Usually Always 
 
Incomplete 
evacuation 
Never Rarely Sometimes Usually Always 
Abdominal pain Never Rarely Sometimes Usually Always 
 
Time needed for 
defaecation (min) 
<5 5-10 10-20 20-30 >30 
Assistance for 
defaecation 
Without 
assistance 
Laxatives Digital assist./ 
enema 
  
Unsuccessful 
attempts / day 
Never 1-3 3-6 6-9 >9 
Duration of 
constipation (yrs) 
0 1-5 5-10 10-20 >20 
 
 
Table 1.5 ROME II criteria for constipation.100 
Complaints 12 weeks in the previous year, which do not need to be consecutive 
Symptoms  Fewer than three bowel movements per week 
(two of which must be present at least 25% of 
the time) 
Hard or lumpy stools 
 Straining with defaecation 
 A sensation of incomplete evacuation 
 A sensation of anorectal obstruction 
 The use of manual manoeuvres to assist 
defaecation 
 
 
be caused by disturbed motility of the colon.104-106 Outlet obstruction can 
be caused by a pelvic floor dyssynergia,105,107 but also anatomical 
obstructions, like carcinoma, rectal prolapse, intussusception, enterocele 
and rectocele can present as an outlet obstruction.108,109 Functional 
constipation can be caused by different aetiologies. Decreased rectal 
sensitivity in congenital disorders, like Hirschsprung’s disease, anorectal 
malformations and spina bifida, cause constipation.110-112 A wrong diet or 
some medications can produce constipation.109 Further factors are 
psychosocial disorders,113 sexual abuse and physical violence.114 
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Constipation is often seen in patients after urogenital or anal 
surgery.83,15-117 Some patients suffer from idiopathic constipation, in 
these patients the aetiology of constipation is unknown.118 
After thorough medical history and physical examination anorectal 
physiologic testing is performed in patients with constipation to evaluate 
the severity and aetiology of the constipation before deciding what 
treatment is appropriate. The diagnostic methods are about the same as in 
faecal incontinence: anorectal manometry, rectal sensitivity and capacity 
measurements, pudendal nerve terminal motor latency time 
measurements and defaecography.119-122 Defaecography is important to 
demonstrate a pelvic floor dyssynergia or a rectal prolapse, 
intussusception or rectocele.123 In constipated patients a sigmoidoscopy 
or a colonoscopy is performed when indicated to exclude other causes of 
constipation.97 Additional colonic transit time measurements are done to 
determine the severity of constipation or location of dysmotility and to 
assess the therapeutic response.122,124-126 Colon transit time can be 
determined by radio opaque markers, radio isotopes or colon 
manometry.127 In a transit time study with radio opaque markers only a 
few radiographs will be taken. This investigation is the most accessible 
and therefore often used as a screening tool.128 This is best performed by 
administration of in total 30 radio-opaque markers during three days; 
every day ten markers are taken and each day the markers have a 
different shape. At the fourth day a conventional abdominal radiograph 
has to be taken. In the literature upper normality limits for total colonic 
transit time vary from 45 to 62 hours.129 Radio isotope ingestion provides 
more accurate information about the transit through individual colonic 
regions because of the possibility of frequent observations and the clear 
delineation of the entire colon, which is important for selection of 
patients for segmental colectomy.124 Colon manometry has developed in 
recent years. The pan-colonic pressure with its response to waking and 
meals can be measured during a whole digestive cycle by a capsule with 
pressure sensor. This may represent a useful tool for the study of 
physiology and pathology of colonic motor disorders. It is also possible 
to use solid state catheters, but the maximum number of recording 
sensors available is notably reduced.130 It is important to realize that 
these tests are not without problems as abnormal results are also found in 
asymptomatic controls.122 
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TREATMENT OF CONSTIPATION 
Conservative 
The treatment of constipation starts with medication and dietary 
modification (fibre intake) with increasing fluids to achieve a softer 
consistency of the stool. Laxatives and colonic enemas can be 
effective.109 These treatments are often associated with side effects131 and 
results are not always satisfactory.132 PFR is satisfactory in a number of 
patients with evidence of pelvic floor dyssynergia.133 Colonic irrigation 
can be used when other conservative methods are not successful.37,134 
Retrograde and antegrade irrigation techniques can be used as described 
by faecal incontinence.  
Surgery 
The MACE procedure is described in the treatment of faecal 
incontinence,90 but is originally developed for the treatment of 
constipation.135 In patients with a rectocele a posterior colporrhaphy can 
be performed.136 The SNM is another procedure that is successful in 
constipation.97 A study of Holzer et al., including patients with slow 
transit and pelvic outlet obstruction, reports good results with improved 
quality of life.137 A review suggests that the clinical effect of SNM in 
idiopathic constipation is improvement of evacuation with decreased 
straining, increased frequency of defaecation, decreased abdominal pain 
and bloating, but only a few studies with small numbers of patients, a 
short length of follow-up and different baseline definitions have been 
performed.1 Surgical resections for constipation must be restricted for 
intractable constipation and strict patient selection is very important.138 
The patients with outlet obstruction and the patients with irritable bowel 
syndrome should be excluded, because in these cases there is no 
indication for colon resection.123,139 The indication for a subtotal 
colectomy with ileorectal anastomosis exists in a selected group of 
patients with a slow transit constipation.123 The results are reasonable in 
case of appropriate patient selection, but complaints of abdominal pain 
and bloating often persist.140,141 It is also possible that abdominal pain, 
faecal incontinence and recurrent constipation develop after surgery, 
which has a negative impact on quality of life.125,142 However, in the 
study of FitzHarris et al., 93% of the patients reported to undergo the 
subtotal colectomy again when given a second chance.139 The study of 
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Glia et al. investigated 17 patients with slow transit constipation and 
concluded a trend towards worse in patients with abnormal 
antroduodenal manometry.141 So before performing a (sub)total 
colectomy, antroduodenal manometry should be performed. In patients 
with isolated segmental slow transit constipation a segmental colectomy 
can be performed, resulting in the same results with less side-effects like 
faecal incontinence.123 To decrease the risk of acquired faecal 
incontinence, a segmental colectomy should be considered in patients 
with an abnormal sphincter function,143 to prevent intractable diarrhoea.  
Finally, in some patients an end-colostomy can give good results, and is 
sometimes preferred above colectomy,95 especially in wheelchair bound 
patients. 
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AIM AND OUTLINE OF THIS THESIS 
Defaecation disorders are distressing for patients and affecting their lives 
severely. A proportion of patient is resistant to medication and dietary 
modifications.144 The aim of this thesis is to investigate different 
conservative and surgical treatment modalities for defaecation disorders.  
All studies were performed in the period 2001-2007. All but two of the 
studies described in this thesis were performed only at the Department of 
Colorectal Surgery of the Maastricht University Medical Centre. The 
collaborative study described in Chapter 3 was performed in the 
Maastricht University Medical Centre and the Academic Medical Centre 
of Amsterdam with patients from 16 hospitals in the Netherlands. The 
interdisciplinary study described in Chapter 6 was carried out in 
collaboration with the Department of Neurosurgery, Paediatric 
Neurology, Urology, Colorectal Surgery and Paediatric Surgery in the 
Maastricht University Medical Centre.  
Retrograde colonic irrigation (RCI) is a treatment that has been used 
already in the past, but there are only a few studies.37,38 The RCI can be a 
very successful treatment for defaecation disorders before surgery and 
after unsatisfactory outcome of surgery, but more investigations need to 
be done to delineate the effect of RCI in faecal incontinence and 
constipation. Chapter 2 delineates the success and pitfalls of RCI in 
patients with defaecation disorders in a prospective study.  
PFR can be successful in some patients.33 However, when PFR and other 
conservative treatments are failing, surgery can be performed. SNM is 
the first choice of treatment, because of the minimal invasive nature of 
the procedure and the fact that a test treatment is possible before the 
definitive surgical procedure is performed. SNM has been proved to be 
successful in patients with faecal incontinence, and also in voiding 
disorders.41,45,77,145-149 Chapter 3 describes patients with faecal 
incontinence after a failed standardized PFR program,33 who are treated 
with SNM. Chapter 4 describes patients with faecal incontinence and an 
implantation with SNM that are stimulated with a voltage below the 
sensitivity threshold. The sensitivity threshold is the threshold voltage 
that causes a sensation around the anus during stimulation. When having 
a therapeutic effect of SNM below the sensitivity threshold, this proves 
that SNM is not working by solely a stimulatory motor effect, but most 
probably by modulating the rectal and central nerve pathways. The effect 
of SNM on patients with constipation and in patients with congenital 
malformations, like spina bifida has only been investigated in a few small 
Thesis_Lansen_Koch_v5.pdf   23 16-4-2009   11:21:26
   24 
studies.41,42,97,150-153 Chapter 5 assesses SNM in patients with spina 
bifida. 
In patients suffering from faecal incontinence and dysfunction of the anal 
sphincters, a sphincter replacing operation can be performed: a DGP or 
an ABS implantation.13,18,21,71-77 The success of DGP in patients with an 
anorectal malformation (ARM) is not as good as in other patients with a 
DGP. A study with short-term follow-up was performed in the past.72 A 
longer follow–up of patients with an ARM, who were treated with DGP, 
is presented in Chapter 6.  
Chapter 7 reports the success of RCI in defaecation disorders after DGP 
in a cross-sectional study. RCI can be used after all failing surgical 
procedures. Chapter 8 reports the results of RCI in patients with faecal 
incontinence after a Low Anterior Resection for rectal carcinoma. 
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ABSTRACT 
PURPOSE 
Retrograde colonic irrigation (RCI) is a possible treatment for defaecation disorders when 
conservative treatment or surgery has failed. The aim of this prospective study was to investigate 
its effectiveness. 
 
PATIENTS AND METHODS 
Patients were divided into three groups: Those with faecal incontinence (A), constipation (B) or 
both (C). The Biotrol® Irrimatic pump or the irrigation bag was used for colonic irrigation. 
Patients completed a questionnaire at baseline and after three months, six months and one year, as 
well as a Short Form 36 health survey and an American Society of Colon and Rectal Surgery 
quality of life questionnaire at baseline and after six months. 
 
RESULTS 
The study included 39 patients (26 women; mean age 58.0 years). In group A, 11 of 18 patients 
were pseudocontinent for faeces at three months (P<0.001). Parks’ incontinence scores decreased 
for all patients in this group at three months (P<0.001), six months (P=0.036) and one year 
(P=0.005). In group B, three of ten patients reported a major improvement. The mean score for 
the feeling of incomplete evacuation decreased at three months (P=0.007), six months (P=0.013) 
and one year (P=0.036). In group C, six of ten patients became pseudocontinent for faeces 
(P=0.009) and three reported improvement in constipation. The overall quality of life scores 
improved (P=0.012).  
 
CONCLUSION 
RCI is an undervalued but effective alternative treatment for intractable defaecation disorders. 
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INTRODUCTION 
Faecal incontinence and constipation are distressing conditions with a 
great impact on daily life. Faecal incontinence affects approximately 
1-4% of the population older than 40 years;1 it is more common in 
women and increases with age. Chronic constipation is a common self-
reported gastrointestinal problem that affects between 2 and 34% of 
adults.2 About 30% of patients with faecal incontinence also suffer from 
constipation.3,4  
The preferred treatment of these disorders is conservative, with dietary 
and medical measures and eventually biofeedback therapy. Modification 
of diet and medication can alter the consistency of stool,5 but results are 
often unsatisfactory.6,7 Biofeedback therapy to train the pelvic floor is 
beneficial in some patients, but the benefits seem to decrease with 
time.8-12 Some recovery may occur after repeated biofeedback.13  
There remains a group of patients with intractable and incapacitating 
symptoms, despite conservative measures. Traditionally, surgery is the 
next step for these patients. However, retrograde colonic irrigation can be 
considered first.14-16 Colonic irrigation is also possible as an additional 
therapy after failed surgery for faecal incontinence and intractable 
constipation before colostomy, which is considered in most of these 
patients.14 Irrigation for constipation alters the consistency of stool and 
provokes the desire to defaecate, thereby increasing the defaecation 
frequency. Irrigation for incontinence cleans the bowel and increases the 
time for arrival of new stool in the rectum resulting in pseudo-
continence.17 
Colonic irrigation can be performed in different ways: retrograde rectal 
irrigation, or irrigation through a colostomy, and antegrade irrigation by 
means of a Malone antegrade colonic enema (MACE), a transverse or 
sigmoid colostomy.14,18-25 Only a few studies have assessed retrograde 
colonic irrigation (RCI), and all reported a beneficial effect.14,16,26-30 
The aim of the present prospective study was to investigate the 
effectiveness of RCI and its influence on quality of life for the treatment 
of defaecation disorders. 
PATIENTS AND METHODS 
All patients were referred to the Department of Colorectal Surgery of the 
Maastricht University Hospital for the treatment of faecal incontinence, 
constipation or both. All consecutive patients who started RCI from June 
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2003 to June 2004 were invited to join the study. The patients received 
detailed information about the study and gave informed consent before 
joining. They started RCI after failed conservative treatment or after 
(partially) unsuccessful surgical treatment for their defaecation disorder.  
Faecal incontinence was defined as involuntary loss of solid or liquid 
stool more than once a week. The extent of faecal incontinence was 
determined using Parks’ score, ranging from 1 (complete continence) to 4 
(incontinence for solid faeces).31 Constipation was defined as less than 
two bowel movements per week, straining or having had a feeling of 
incomplete evacuation for more than 50% of bowel movements during 
the previous year. The patients gave scores for incomplete evacuation, 
straining, bloating and abdominal pain on defaecation using a scale 
adapted from the Wexner constipation score: 1 (always, or with every 
defaecation), 2 (often, more than once a week), 3 (sometimes, more than 
once in four weeks, but less than once a week) or 4 (never).32 
Patients were divided into three groups: those with faecal incontinence 
(group A), those with constipation (group B) and those with a 
combination of faecal incontinence and constipation (group C). 
Patients filled out a baseline questionnaire regarding their medical 
history, defaecation pattern and medication. They completed another 
questionnaire at three months, six months and one year, which asked 
them about the time needed for RCI, the amount of water used, the 
frequency of irrigation and possible side-effects. Most patients irrigated a 
second time in the same session, and the total amount of water used in 
one session was assessed. The endpoints were defined as successful RCI 
for the patients and a significant improvement in quality of life. The RCI 
was considered successful when patients with faecal incontinence 
became pseudocontinent and those with constipation no longer had a 
feeling of incomplete evacuation or straining during defaecation. In the 
combination group, RCI was considered successful when faecal 
incontinence, constipation or both ceased. 
Secondary endpoints were assessment of irrigation details and side-
effects.  
A Biotrol® Irrimatic pump (B.Braun®, Melsungen, Germany) or the 
irrigation bag (B.Braun®, Melsungen, Germany) was used for RCI,29,30 
with the patient choosing the more convenient of the two. The pump set 
consists of a pump, a tube and a cone tip which is introduced in the anal 
canal. All patients were instructed in the same way by the same physician 
to sit on the toilet while irrigating and were advised to start the irrigation 
daily with 500 ml of tap water. Thereafter, the frequency and the amount 
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of water were adjusted until a satisfactory result was achieved, with a 
maximum of two litres at once. Eventually, patients could irrigate a 
second time in the same session to clean the bowel of the remaining 
faeces. Water used for irrigation was at body temperature, and soap or 
laxatives were added when necessary. The pump worked on a storage 
battery and the speed of water ejection could be regulated. The working 
mechanism of the irrigation bag was similar, except that the water 
ejection used gravity. 
Quality of life 
Patients were asked to complete a validated Dutch translation33 of the 
Short Form 36 health survey (SF-36; Medical Outcomes Trust, Waltham, 
Massachusetts, USA®)34,35 and the American Society of Colon and Rectal 
Surgery (ASCRS) quality of life questionnaire36 at baseline and after six 
months. The ASCRS questionnaire (29 items) measures quality of life 
specifically in association with faecal incontinence in four distinct 
domains: lifestyle, coping and behaviour, depression and self-perception, 
and embarrassment.36 The SF-36® is not disease-specific, using a scale of 
1-100 (high score indicates better functioning) in eight domains: physical 
functioning, role physical, vitality, social functioning, role emotional, 
pain, general health perception and mental health.34,35 
Statistical analysis 
Data analysis was performed by SPSS® version 14.0 (SPSS, Chicago, 
Illinois, USA). The Wilcoxon Signed ranks non-parametric test for paired 
samples was used to test the significance of the overall outcome of 
colonic irrigation during follow-up compared with baseline values. To 
test the difference between groups, the Mann-Whitney U test for 
independent samples was used (non-parametric tests because of the small 
size of the groups). P≤0.050 was considered significant. Data are given 
as mean±SD. 
RESULTS 
Thirty-nine patients were included in the study; 26 were women, and the 
mean age was 58.0±13.5 years. Group A had 18 patients (12 women) 
with faecal incontinence and a mean age of 60.8±12.2 years; group B had 
11 patients (seven women) with constipation and a mean age of 
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55.4±14.6 years; and group C had ten patients (seven women) with a 
combination of faecal incontinence and constipation, and a mean age of 
54.7±16.2 years. The age differences between the groups were not 
significant. 
The baseline mean defaecation frequency per day was significantly 
higher in group A (5.2±3.2) than groups B (3.9±7.7; P=0.009) and C 
(1.1±1.3; P=0.001). The consistency of stool was looser in 17 patients of 
group A (hard, zero; normal, three; diarrhoea: 11; watery, three) than all 
patients in group B (hard, four; normal, two; diarrhoea, five; watery, 
zero) and seven patients of group C (hard, three; normal, one; diarrhoea, 
three; watery, zero). The other patients of groups A (one) and C (three) 
reported variable consistency. 
Before the start of the irrigation, medication to alter the stool consistency 
was used in nine of 18 patients in group A, four of 11 in group B and 
seven of ten in group C. This was psyllium fibres (six patients), 
mebeverine (one) and loperamide (two) in group A, lactulose (two), 
bisacodyl (one) and psyllium fibres (one) in group B, and psyllium fibres 
(four), enemas (two) and magnesium oxide (one) in group C. In total 20 
of all 39 patients used medication. Table 2.1 shows the medical histories 
in each group. 
 
 
Table 2.1 Medical histories of 39 patients. 
 Group A 
n=18 
Group B 
n=11 
Group C 
n=10 
Total 
Hysterectomy 8 2 3 13 
Prolapse surgery 7 4 0 11 
Recto-sigmoid resection 5 1 2   8 
Haemorrhoidectomy 2 3 1   6 
Cholecystectomy 2 2 1   5 
Nucleus Pulposus Herniation 1 2 1   5 
Dynamic graciloplasty 3 0 0   3 
Diabetes Mellitus 1 1 1   3 
Fistula surgery 0 1 1   2 
Anal repair 1 0 1   2 
Multiple Sclerosis 0 0 1   1 
Spina Bifida 1 0 0   1 
Anorectal malformation 1 0 0   1 
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Overall, six patients used the RCI to treat idiopathic faecal incontinence 
or constipation, and the other 33 patients used it after failed or partially 
successful colorectal surgery. Three patients used it as an additional 
treatment for faecal incontinence after a dynamic graciloplasty (DGP), 11 
patients for faecal incontinence, constipation or both after surgery for 
rectal prolapse, and 19 patients after other miscellaneous surgical 
procedures (Table 2.1).  
The results of RCI on defaecation disorders in groups A and B are shown 
in Figures 2.1 and 2.2 respectively. At three months, 11 patients from 
group A were pseudocontinent for faeces (P<0.001), and were considered 
successful. Parks’ scores decreased for all incontinent patients in group A 
from 3.6±0.5 to 2.3±1.0 at three months (P<0.001), 2.7±1.3 at six months 
(P=0.036) and 1.6±0.9 at one year (P=0.005). 
In three of ten patients in group B, the irrigation was successful. In two 
of ten patients in group B (n=11), the feeling of incomplete evacuation 
ceased. There was a major improvement in five other patients (P=0.007). 
There was a major improvement in straining in one patient and complete 
cessation in two (P=0.051), complete cessation of bloating in two 
(P=0.055), and major improvement in abdominal pain in one and 
complete cessation in three (P=0.204). Mean scores measuring the 
feeling of incomplete evacuation for patients in group B reduced from 
1.6±2.5 at baseline to 2.8±2.4 at three months (P=0.007), 3.0±1.7 at six 
months (P=0.013) and 2.8±1.4 at one year (P=0.036). 
Six patients in group C became pseudocontinent for faeces as a result of 
the irrigation (P=0.009) and three patients reported the feeling of 
incomplete evacuation was resolved after RCI; these patients also 
became continent for faeces (P=0.079). 
The total amount of water used at three months was significantly higher 
than at one year (1.8±1.5 vs. 1.7±0.8 l., P=0.014). Other irrigation 
parameters did not change during follow-up (Table 2.2). Table 2.3 
shows irrigation parameters of groups A, B and C at three months. 
Analysis for the separate groups was not possible because data for only 
20 patients were available at one year.   
The mean amount of water used for RCI was significantly higher in 
group A than in group C (2.4±1.9 vs. 1.3±0.8 l.; P=0.030). The frequency 
of RCI per day in patients in group A (0.9±0.3) was significantly lower 
than that in patients in group B (1.3±0.5; P=0.007) and C (0.9±0.2; 
P=0.042); and the time needed for the RCI was significantly higher in 
group A (42.5±20.2 min.) than in groups B (28.6±21.3 min.; P=0.005) 
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Figure 2.1 Success of colonic irrigation for all 18 patients with faecal incontinence (group A) 
at three months. * P<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2  Success of colonic irrigation for ten patients with constipation (group B) at three 
months. * P=0.007; † P=0.051; ‡ P=0.055; § P=0.204 
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or C (25.4±15.6 min.; P=0.027). RCI was mostly performed once a day; 
26 patients in the morning (16 from group A; six from B; four from C), 
seven in the evening (one from group A; two from B; four from C), and 
six irrigated twice a day (one from group A; three from B; two from C).  
The nine patients in group A discontinued taking medication to alter the 
consistency of stool, but another patient started taking psyllium fibres; in 
group B, two of four patients stopped and another patient started taking 
psyllium fibres; in group C four of seven patients stopped taking their 
medication. 
The quality of life scores improved on all domains, except vitality in the 
SF-36® which decreased and role physical which remained unchanged. 
Significance could not be proved for separate domains in the SF-36® and 
ASCRS questionnaires; however, the overall quality of life score 
improved significantly (P=0.012).  
 
 
Table 2.2 Overall irrigation parameters. Mean values (SD). 
 3 months 6 months 1 year P* P† P‡ 
Amount of water used 
(litres) 
 1.8 (1.5)  2.2 (1.5)  1.8 (0.8) 0.206 0.014 0.263 
Frequency of 
irrigation (per day) 
 1.0 (0.4)  1.0 (0.4)  1.1 (0.5) 0.550 0.353 0.328 
Time needed for RCI 
in total (min.) 
 35.3 (20.9)  37.5 (27.8)  36.4 (16.0) 0.376 0.431 0.160 
*Three vs. six months; † three months vs. one year; ‡ six months vs. one year; all Wilcoxon 
Signed ranks test 
 
 
Table 2.3 Irrigation parameters of the three groups at three months. Mean values (SD). 
 Group A Group B Group C P* P† P‡ 
Amount of water used 
(litres) 
 2.4 (1.9)  1.7 (1.2)  1.3 (0.8) 0.262 0.030 0.214 
Frequency of irrigation 
(per day) 
 0.9 (0.3)  1.3 (0.5)  0.9 (0.2) 0.007 0.042 0.194 
Time needed for 
irrigation in total (min.) 
 42.5 (20.2)  28.6 (21.3)  25.4 (15.6) 0.005 0.027 0.401 
*Group A vs. group B; † group A vs. group C; ‡ group B vs. group C; all Mann-Whitney U test 
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Negative side-effects such as leakage after irrigation, abdominal cramps 
and bloating were reported by 23 patients (Figure 2.3). Nine patients 
stopped RCI, seven because the result was unsatisfactory and two 
because the incontinence or constipation improved spontaneously. Two 
patients changed the irrigation from retrograde irrigation to antegrade 
irrigation by an appendicostomy. 
Table 2.4 shows a summary of the results to enable a comparison with 
other studies of retrograde colonic irrigation. 
DISCUSSION 
In this study 11 of 18 patients with faecal incontinence became 
pseudocontinent for faeces and, in some constipated patients, the 
straining, incomplete evacuation or both resolved. In addition, ASCRS 
and SF-36® questionnaires showed a significant overall improvement of 
quality of life.  
Defaecation disorders include a broad group of conditions: faecal 
incontinence, constipation and a combination of both. This study, 
describing results in all three groups, has a heterogeneous study 
population and relatively small groups, so the results should be 
interpreted cautiously. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Side-effects of colonic irrigation in 39 patients. 
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Table 2.4 Summary of results from studies of retrograde colonic irrigation. 
Total Faecal 
incontinence
Constipation Faecal 
soiling 
Combination Stopped 
irrigation 
Author 
n n Success n Success n Success n Success  
Briel14    32 16 38%   16 79%   18% 
Gosselink16  169 71 41% 37 65% 32 47% 29 79% 55% 
Krogh26    37   9 44% 16 19%   12 91%  
Crawshaw27     48 33 48% 15 53%       8% 
Scholler-Gyure28   41 11 66% 11    19   
Koch29   46 24 37% 11 30%   11 29% 16% 
Cazemier30   88 54 87% 34 79%     23% 
Present study   39 18 61% 11 30%   10 60% 23% 
 
 
There have been only a few studies of RCI, but all reported a beneficial 
effect (Table 2.4).14,16,26-30 In all but two of the studies the subjective 
beneficial effect of RCI was considered as success.14,16,26,27,30 Only the 
studies of Scholler-Gyure and co-workers28 and Koch and colleagues29 
considered pseudocontinence and resolved constipation as success. In the 
present study, success was also defined as a resolution of the symptoms 
of faecal incontinence (pseudocontinence) and constipation. The success 
rate of 30% (three of ten) for constipation in this study is worse than 
those reported by Gosselink and co-workers,16 Crawshaw and 
colleagues27 and Cazemier et al.,30 but better than those of Krogh and co-
workers.26 The differences are probably explained by the differing study 
designs, populations and outcome measures.  
Five studies of irrigation included patients with different aetiologies for 
their defaecation disorders,14,26,27,30 one had children with spina bifida28 
and another patients with DGP.29 In the retrospective study of 41 children 
with spina bifida, 66% (27 children) became pseudocontinent.28 In a 
cross-sectional study of patients with defaecation disorders after DGP, 
37% of patients reached pseudocontinence and 30% had resolved 
constipation. Seven patients (16%) stopped the irrigation therapy.29  
In a cross-sectional study of the long-term feasibility and outcome of RCI 
in 169 patients with miscellaneous defaecation disorders, RCI, used for a 
median of 56 months, was reported to be effective and beneficial by 91 
patients (54%).16 Fifty-five per cent of the patients discontinued RCI: all 
78 patients in whom RCI was not effective and 15 who did benefit. The 
overall success rate was 45%. Another cross-sectional study in 25 adults 
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and 43 children with defaecation disorders found that 87% of patients 
with faecal incontinence and 79% of patients with constipation were 
satisfied with their results.30  
In these studies, the rate of stopping irrigation therapy varied 
considerably (Table 2.4). In a retrospective study of 16 patients with 
faecal incontinence and 16 with soiling with a mean follow-up of 18 
months, six of 32 patients (19%) discontinued RCI.14 In another 
retrospective study of 48 patients with miscellaneous defaecation 
disorders and a median follow-up of 11 months, four of 48 patients (8%) 
stopped.27 The study with the highest percentage (50%) of patients 
stopping RCI had a long follow-up.16 However, the study with the 
longest follow-up (the mean duration of use was given as 81.6 months) 
reported a lower rate of patients stopping RCI (23%).30 In the present 
study, the rate of patients stopping was also 23% (nine patients); patients 
stopped mainly because it was not effective. However, the follow-up was 
only one year, and it is possible that more patients would have stopped 
the therapy with more time.  
RCI can be used as primary therapy after failed conservative treatment or 
as additional therapy after failed surgical treatment of faecal incontinence 
or constipation. In the present study, three patients used the RCI as 
additional therapy after failed DGP and 11 patients after a procedure for 
rectal prolapse. Rectal prolapse is frequently associated with defaecation 
disorders. Several surgical techniques have been described and used for 
the treatment of complete rectal prolapse. Abdominal rectopexy offers 
the best anatomical results and lowest recurrence rates, but intractable 
constipation is frequently reported after rectopexy.37 Constipation after 
abdominal rectopexy is probably associated with the rectal denervation 
after lateral dissection of the rectum,38 and faecal incontinence can occur 
when rectopexy is combined with sigmoidectomy.39  
A remarkably high number of patients (13; 33%) in the present study had 
a history of hysterectomy (Table 2.1). Previous studies have shown that 
abdominal hysterectomy is a risk factor for developing faecal 
incontinence, which is increased further by concomitant bilateral 
salpingo-oopherectomy.40 The onset of constipation after hysterectomy 
has also been reported.41  
The patients in the present study used normal tap water for irrigation. 
Electrolyte imbalance, especially hyponatraemia, as a result of irrigation 
with tap water has been rarely described.42 None of the patients had 
developed hyponatraemia, but periodic evaluation of serum electrolytes 
could be considered. Tap water is thought to be the safest irrigation fluid, 
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because other solutions are hypertonic and have a stimulatory effect on 
the bowel. These hypertonic solutions constitute a much greater risk for 
electrolyte disturbances.43  
CONCLUSION 
RCI with tap water is an undervalued but effective alternative for the 
treatment of intractable defaecation disorders. RCI should be considered 
before performing surgery for defaecation disorders. It can also be 
effectively used as an additional or salvage treatment after colorectal 
surgical procedures for faecal incontinence and constipation. 
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ABSTRACT 
PURPOSE 
Sacral Nerve Modulation (SNM) is a minimally invasive technique for the treatment of faecal 
incontinence. This study investigates the results of SNM after negative outcome of a standardized 
pelvic floor rehabilitation (PFR) programme for the treatment of faecal incontinence.  
 
PATIENTS AND METHODS 
A prospective cohort study was performed between December 2001 and August 2007. 
Consecutive patients that visited the outpatient department for faecal incontinence were included 
in a multicentre study and treated with standardized PFR. Those with an unsuccessful result who 
were eligible for SNM were included in the present study. Failures at test stimulation or SNM 
received another treatment. Clinical outcome, Vaizey scores and quality of life (EQ-5D and 
HAQL) were assessed during follow-up in patients with SNM and in patients with other 
treatments (OT). Adverse events (AE) were documented. 
 
RESULTS 
Thirty-five patients (mean age 59.7 years; 31 females) were included. Twenty-one had a 
successful test stimulation and 19 patients proceeded to a SNM implant. Incontinence episodes 
per week decreased significantly from 11.1±11.7 to 1.9±2.6 during test stimulation (P<0.0001) 
and SNM over 24.1 months follow-up. The overall success rate was 49% (17/35). The patients 
with unsuccessful test stimulation or SNM received OT. The Vaizey score improved in both SNM 
(18.2±3.5 vs. 13.7±4.8; P=0.004) and other treatment (18.2±3.5 vs. 13.9±6.9; P=0.019). The 
HAQL scale improved significantly during SNM in all subscales (P<0.005), but not in the other 
treatment group. Eight AE occurred during test stimulation (23%) and six AE after permanent 
implantation (26%). 
 
CONCLUSION 
Sacral nerve modulation improves disease specific quality of life significantly compared with 
other treatment. 
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INTRODUCTION 
The aetiology of faecal incontinence is multifactorial.1 Faecal 
incontinence is initially treated with conservative measures including 
dietary adjustments or medication. Pelvic Floor Rehabilitation (PFR) is 
commonly used as the next step in conservative treatment.2 This 
combines pelvic floor muscle training with biofeedback and electrical 
stimulation.3 An intra-anal electromyography sensor, anal manometry 
probe or peri-anal surface electromyography electrodes are used to help 
the patient learn how to exercise the external anal sphincter. A balloon 
system is used to train the patient to recognize the stimulus of rectal 
distension, for perception of the sensory threshold and expansion of the 
rectum to improve the discrimination of smaller rectal volumes.4 Success 
rates vary from 0-100%,4-6 but the benefits of PFR decrease with 
time.3,7-10 Some recovery may occur after repeated biofeedback.11  
Surgical treatment is considered when conservative treatment fails. 
Sacral Nerve Modulation (SNM) is minimally invasive,12-15 and its 
effectiveness can be predicted by peripheral nerve evaluation (PNE), 
which when successful is followed by a test stimulation period. A 
successful test stimulation is succeeded by permanent implantation.12 The 
reported success rate of SNM ranges from 55 to 100%.12,14-17 Precise 
criteria predicting success of SNM are not yet fully identified.16 
This study investigates the efficiency of SNM for the treatment of faecal 
incontinence in patients after an unsuccessful standardized PFR program. 
In addition, in a separate analysis, it investigates the value of the other 
treatments (OT) after an unsuccessful SNM. 
PATIENTS AND METHODS 
Patients 
The faecal incontinence therapy (FIT) study investigated 281 patients 
with faecal incontinence from 16 hospitals in the Netherlands in a 
prospective cohort multicentre study between December 2001 and 
August 2007.6 This was approved by the medical ethics committees in all 
the hospitals involved. Inclusion criteria included faecal incontinence for 
at least six months, a Vaizey score18 of at least 12, and failure of 
conservative treatment. Patients under the age of 18 years, and patients 
with an anorectal tumour, chronic diarrhoea, overflow incontinence, 
proctitis, soiling, previous ileo-anal or colo-anal anastomosis and/or 
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grade III rectal prolapse, intussusception or rectocele were all excluded. 
Patients who had received PFR in the previous six months or who were 
considered to be cognitively unable to undergo PFR were also excluded. 
Eligible patients were included in the FIT study after a written informed 
consent.  
Diagnostics 
Their medical history was recorded, including duration, nature, severity 
and possible underlying causes of faecal incontinence. The severity of 
faecal incontinence was assessed with the Vaizey incontinence scoring 
system, ranging from 0 (complete continence) to 24 (fully incontinent).18 
Manometry was carried out with a four-point solid state catheter 
(Konigsberg instrument Inc., Pasadena, California, USA), measuring anal 
resting and squeeze pressures, and anal and rectal pressures during 
straining and coughing. The recto-anal inhibitory reflex was measured 
using this catheter with a balloon. Rectal sensitivity and capacity was 
assessed using a balloon catheter, measuring first rectal sensation 
volume, first urge sensation volume and the maximum tolerated volume. 
Each patient underwent endo-anal ultrasonography (7.5 MHz, SDD 2000, 
Multiview, Aloka, Japan). All external sphincter defects in the entire 
length of the sphincter were considered as external sphincter defects. 
Pudendal nerve terminal motor latency times (PNTML) were assessed 
using a St. Mark’s pudendal electrode (Medtronic USA). Pudendopathy 
was diagnosed when a PNTML was >2.4 ms or an abnormal curve. 
Defaecography was performed to exclude grade III rectal prolapse, 
intussusception or rectocele and to assess pelvic floor function. 
Pelvic floor rehabilitation 
Patients were referred to a specialized physiotherapist for PFR after 
investigation. The protocol of PFR is described elsewhere.6 After the 
standardized PFR programme patients returned to the outpatient 
department and Vaizey scores, anorectal manometry and rectal balloon 
distension were re-assessed. 
The PFR programme was considered unsuccessful when the 
improvement of the Vaizey score was <50%. Consecutive patients with a 
negative outcome after PFR who wanted further treatment were offered 
SNM. A PNE was undertaken when faecal incontinence occurred more 
than once a week. 
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Sacral nerve modulation 
Patients filled out a baseline defaecation diary during three weeks. A 
temporary PNE electrode was inserted and connected to an external pulse 
generator.19 If a three-week test stimulation was successful, a permanent 
electrode, extension cable and pulse generator were implanted.19 The test 
stimulation was considered successful when a decrease of incontinence 
episodes of >50% was achieved. The patients had the pulse generator 
switched on during the day only, because they had no faecal incontinence 
at night. 
Follow-up was scheduled at three, six, 12 and 24 months after permanent 
SNM implantation and included defaecation diary recordings, anorectal 
manometry, rectal sensitivity and capacity estimations by rectal balloon 
insufflation. Vaizey scores were determined and any adverse event was 
recorded. 
Patients with unsuccessful test stimulation or a failing SNM were offered 
OT including retrograde colonic irrigation, anal repair, a sphincter 
replacement technique (dynamic graciloplasty (DGP) or artificial bowel 
sphincter (ABS)) or an end-colostomy.  
Quality of life 
A quality of life-health status questionnaire was used at baseline, after 
PFR and during SNM or OT. The validated EQ-5D questionnaire and 
HAQL scales were used.20,21 The EQ-5D (EuroQol) questionnaire 
comprises five dimensions of health including mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression. Each dimension 
comprises three levels including no problems, some/moderate problems 
and extreme problems. The score in each dimension can be summarized 
resulting in a summary utility value which can range from -0.594 (worst 
imaginable health state) to 1 (optimal health). 
The HAQL (Hirschsprung's disease/anorectal malformation quality-of-
life) scale is a disease-specific quality of life scale especially developed 
for patients with Hirschsprung’s disease. It is composed of items related 
to physical, emotional and social functioning, and disease-related 
symptoms.21 The 42 items of the questionnaire were combined to form 
three subscales including constipation, faecal incontinence and 
psychosocial functioning. The four response categories, ranging from 
‘never’ to ‘very often’, were recoded and linearly transformed to a scale 
from 0 to 100, with higher scores indicating better levels of quality of 
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life. This scale substantially correlated with selective scales of the SF-
36,22 which is an established generic quality-of-life instrument.  
Data analysis 
Data analysis was performed by using SPSS 14.0 (SPSS release 14.0, 
SPSS Inc. Chicago, Illinois, USA). The t-test for paired and independent 
samples was used. P<0.050 was considered statistically significant. 
Parametric data are given as mean±SD. Analysis was performed 
according to the intention to treat principle. 
RESULTS 
Baseline 
Thirty-five patients who had failed the PFR program were included. The 
mean age was 59.7±11.4 years and 31 (89%) were female. The obstetric 
and other medical history is shown in Tables 3.1 and 3.2. The duration of 
faecal incontinence was a mean of 8.5±8.1 years. Thirteen (37%) patients 
used constipating medication including loperamide (four) or psyllium 
fibres with low fluid intake (nine). Twenty-one (60%) patients had a 
pudendopathy. In 27 (77%) patients a lesion of the anal sphincter was 
seen on endo-anal ultrasound, including ten (29%) with an external anal 
sphincter defect and three (9%) with a combined defect of the internal 
and external anal sphincters. The most severe defect of the external anal 
sphincter was not more than 17% of the circumference in the entire 
length of the sphincter. Defaecography revealed a grade I or II rectocele 
in 16 patients and a grade I or II intussusception and/or grade I or II 
rectal prolapse in 13 patients. In six patients both entities were present. 
 
 
Table 3.1 Obstetric history of the 29 female patients. 
Obstetric history Number of patients (%) 
Breech delivery  2 (7) 
Prolonged labour  11 (38) 
Birth weight > 4 kg  11 (38) 
Assisted delivery (vacuum/forceps)  4 (14) 
Episiotomy  19 (66) 
Rupture  18 (62) 
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Table 3.2 Previous medical history (35 patients). 
Medical history Number of patients (%) 
Hysterectomy  16 (46) 
Prolapse surgery  7 (20) 
Fistula surgery  2 (6) 
Haemorrhoidectomy  6 (17) 
Anal repair  4 (11) 
Maximal anal dilatation  2 (6) 
Nucleus Pulposus Herniation  3 (9) 
Cholecystectomy  4 (11) 
 
 
Sacral nerve modulation 
A PNE was possible in all but one patient (34) and the test stimulation 
was successful in 21 (60%). Incontinence days and episodes per week 
decreased significantly during test stimulation compared with PFR 
(1.3±1.5 vs. 4.1±1.8; P<0.0001 and 1.9±2.6 vs. 11.1±11.7; P<0.0001) 
and these results were maintained during SNM (Figure 3.1). Two 
patients did not want to proceed with permanent implantation. One 
patient complained of leg pain and the other became continent during the 
test stimulation and remained so afterwards. All the other 19 patients had 
a permanent implant. The average time from PNE to implantation was 
3.4±3.0 months. The mean follow-up after implantation was 24.1±14.0 
months. The mean stimulation voltage was 2.1±0.8 Volts at a follow-up 
of three months and did not change during follow-up.  
In three patients the SNM was stopped owing to an unsatisfactory result. 
One of these three then had an ABS and two started colonic irrigation. 
The overall success rate of SNM was 49% (17/35), rating the patient with 
persisting continence after test stimulation to the successful group. 
There were 18 patients who had an unsuccessful PNE or test stimulation 
and who failed after permanent implantation. These proceeded to OT 
modalities including retrograde colonic irrigation (RCI) (four), anal 
sphincter repair (AR) (one), DGP (one), ABS (two), awaiting ABS (one), 
and end-colostomy (three). Two patients with diarrhoea used loperamide 
when needed. One patient experienced spontaneous improvement of 
incontinence one year after the PFR and in two treatments was stopped 
because it was no longer desired (Figure 3.2).  
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Figure 3.1 Box-and-whisker plot showing median incontinence days and episodes at baseline 
and during follow-up after SNM. * Statistically significant compared with PFR 
value. Numbers represent number of patients at follow-up. 
 
 
 
Four patients in the SNM group achieved complete continence for faeces 
and 13 patients reported faeces loss less than once a week. Seven of the 
18 patients in the OT group achieved complete continence for faeces, and 
ten patients reported faeces loss less than once a week compared with 
two after PFR. 
Diagnostics 
Pudendopathy was present in 22/35 (63%) of patients. In five this was 
bilateral. Seven (32%) of the 22 patients with pudendopathy had a 
successful SNM. Two (25%) of the eight patients with an external 
sphincter defect had a successful SNM.  
The results of anorectal manometry and rectal balloon insufflation at 
baseline, after PFR and during SNM (one year) are shown in Table 3.3. 
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The rectal pressure during coughing increased significantly after PFR, 
while the other parameters did not change significantly. There was no 
significant change in resting and squeeze pressures, first rectal sensation 
volume and first urge sensation volumes between SNM and PFR 
(Figure 3.3). The maximum tolerated volume decreased significantly 
during SNM compared with the values after PFR (Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Patient flow in the study. FIT, faecal incontinence therapy; PNE, peripheral nerve 
evaluation; TS, test stimulation; SNM, sacral nerve modulation; OT, other 
treatment; LOP, loperamide; RCI, retrograde colonic irrigation; AR, anal repair; 
DGP, dynamic graciloplasty and ABS, artificial bowel sphincter.  
239  FIT patients  
32 successful 207 unsuccessful 
35 PNE 
1 negative PNE 34 TS 
21 successful 14 unsuccessful 
14+1 (pain at stimulation) 19 SNM  remained continent after TS 
17 long-term success 15+3 (failure of SNM) 
18 OT 
3 colostomy 1 AR 3 ABS 2 LOP 1 DGP 4 RCI 
2 Drop out 
1 conservative 
1 improvement 
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Figure 3.3 Box-and-whisker plot showing resting and squeeze pressure after PFR and during 
SNM. Numbers represent number of patients at follow-up. 
 
Vaizey score and quality of life 
The Vaizey scores and quality of life scales EQ-5D and HAQL were 
assessed at a mean follow-up of 33.4±11.7 months after OT or SNM.  
The Vaizey score improved significantly from 20.1±2.6 at baseline to 
18.2±3.5 after PFR (P=0.0005). This improved further to 13.7±4.8 after 
successful SNM (P=0.004) and after OT to 13.9±6.9 (P=0.019). The 
Vaizey score at baseline was significantly better in the SNM group 
compared with the OT group (18.9±2.5 vs. 20.9±1.4; P=0.006).  
Thirty-three patients filled out quality of life questionnaires. The quality 
of life changed significantly during SNM in all subscales of the HAQL 
scale, while the EQ-5D did not. In the OT group there was no significant 
change in either scale (Table 3.4). 
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Adverse events 
Eight adverse events (AE) in eight patients occurred during test 
stimulation in 34 patients (0.24 AE per patient). Three had incorrect  
placement of the temporary electrode, four had dislodgement and in one 
occurred an electrode break.  
After permanent implantation in 19 patients, six AE were recorded in 
five (0.32 AE per patient). One had pain during stimulation with 
increasing resistance and decreasing efficacy. SNM was stopped and 
colonic irrigation instituted. Another required local surgery because of 
pain at the pacemaker site and subsequently the electrode replaced. One 
patient complained of pain in the foot during stimulation regardless of the 
electrode settings. Two patients had an infection of the permanent 
implant which was treated with antibiotics, one of whom needed a 
revision. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Box-and-whisker plot showing the results of rectal balloon insufflation after PFR 
and during SNM. FRSV, first rectal sensation volume; FUSV, first urge sensation 
volume; MTV, maximum tolerated volume. Numbers represent number of patients 
at follow-up. 
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DISCUSSION 
Success after PFR for faecal incontinence has been reported to range 
from 0 to 100%, but in these studies severity of faecal incontinence 
differed sometimes considerably.4,5,23 A systematic review suggested that 
biofeedback is helpful and has a role in the treatment of faecal 
incontinence, but different selection criteria, lack of controls and 
validated outcome measures create inconsistencies when evaluating these 
results. The initial 46 studies reviewed varied in the method of 
biofeedback and criteria for success. Of the 34 studies including a total of 
566 patients which fulfilled the entry criteria, 49% achieved satisfactory 
continence.4 In the FIT study a standardized PFR programme was found 
to be successful in only 13% of patients6 but the severity of incontinence 
was worse compared with most other studies. 
A significant improvement in squeeze pressure after PFR and first rectal 
sensation volume has been reported after PFR.24,25 In the present study, 
however, only a significant increase in anal pressure with coughing was 
found in the SNM group (Table 3.3). Several studies have reported 
conflicting results of the effect of SNM on squeeze pressure, ranging 
from no change to a significant increase.16,26 Any increase in squeeze 
pressure is most probably caused by a high stimulation voltage causing a 
transformation of muscle fibre type. It is also possible to achieve a 
therapeutic effect by stimulating below the sensitivity threshold as 
demonstrated in a previous study.27 The clinical significance of these 
parameters is still not understood.  
The population size of the present study is too small to compare anorectal 
physiological parameters before and after treatment with SNM. Statistical 
significance was reached only for the decrease of maximum tolerated 
volume, but this should be interpreted with caution. It is possible that 
more patients in the multicentre FIT study of Terra et al.6 would have 
been eligible for SNM but were not identified for recruitment. 
In patients treated by SNM after failed PFR, the present study has shown 
success in 49%, which is lower than the mean results reported by other 
studies. This may be explained by differences in the study populations, 
which include patients with varying Vaizey scores above 12, and 
inclusion of patients with variable degrees of sphincter damage. 
In the present study, the Vaizey incontinence score has been used as the 
assessment of clinical incontinence, because it is reproducible and 
correlates well with the clinical impression.18 The severity of the score 
also reflects the impact of faecal incontinence on the quality of life 
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measured by the EQ-5D.28 The Vaizey score improved significantly in 
both the SNM and the OT groups. The EQ-5D and HAQL questionnaires 
were used in this study because they had already been applied in the FIT 
study.6 The HAQL questionnaire had been used in the FIT study21 
because a validated Dutch version of the ASCRS quality of life scale was 
not available when the study was initiated.29 The validated EQ-5D scale 
was also used in the FIT study, because it gives a good representation of 
the general quality of life.21 As expected, the quality of life improved 
significantly after SNM but surprisingly not after OT although the 
Vaizey score, which usually correlates well with general quality of life, 
did so.28 The OT group contains patients who had failed SNM, and these 
patients already had a significantly lower Vaizey score at baseline. The 
faecal incontinence and its aetiology were probably more severe in this 
group. It is noteworthy, however, that the Vaizey score during OT was 
not significantly different from patients after a successful SNM. A 
subanalysis of the quality of life and Vaizey scores of the different 
treatment subgroups included in OT was not possible because of the 
small number of patients. A randomized study between SNM and other 
treatments would be difficult because patients prefer the minimally 
invasive SNM before invasive procedures such as colostomy, ABS and 
DGP.  
A review of SNM for faecal incontinence revealed an AE rate of 0.04 per 
patient for test stimulation and 0.12 AE per patient for permanent 
implantation. The most serious complication was infection of the implant 
requiring removal in three patients.26 Overall, this study recorded an AE 
rate per patient of 0.24 AE per patient during test stimulation. This seems 
high compared with the review of Jarret et al., but this did not include 
wrongly-placed electrodes.26 
Sphincter replacement techniques like ABS and DGP are successful in 
69-85% of patients,30-35 but the indications for this treatment are different 
from SNM. The present evidence indicates that SNM is the surgical 
treatment of choice for most patients with faecal incontinence after failed 
conservative therapy. The minimal invasion, the test stimulation, the 
complication rate and costs which are lower compared to the DGP, ABS 
or colostomy are advantages in favour of SNM.36-38 A sphincter 
replacement technique can be considered when the patient is not eligible 
for SNM or when SNM fails. The end-colostomy is mostly the final 
treatment option. Retrograde colonic irrigation must not be forgotten as 
conservative treatment before or after these treatment modalities.39 
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CONCLUSION 
Sacral nerve modulation is successful in about half of patients 
experiencing an unsuccessful standardized PFR. It improves quality of 
life and continence. Other treatments for patients who fail after SNM also 
result in improved continence.  
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ABSTRACT 
PURPOSE 
The aim of the study was to determine the therapeutic response threshold in patients with 
successful sacral nerve modulation (SNM) for faecal incontinence. 
 
PATIENTS AND METHODS 
Patients who had undergone successful permanent SNM implantation and had been followed up 
for a minimum follow-up of three months were included. The sensitivity threshold and motor 
threshold were determined and correlated with therapeutic response, determining therapeutic 
response threshold. Patients went home with the stimulator set at 0.6 V below the sensitivity 
threshold. Each week the voltage was increased by 0.2 Volts until the sensitivity threshold was 
reached. The effects on anorectal physiology and continence were recorded. 
 
RESULTS 
Eight patients (seven women) with a median age of 58.5 years were included. The median follow-
up was 6.3 months. The median sensibility threshold volume was 50 ml, the median urge 
threshold volume was 140 ml and the median maximum tolerated rectal volume 240 ml. The 
median incontinence episodes and days per week decreased from 5.0 and 3.8 before operation to 
0.7 and 0.7 respectively after follow-up for three months. At anorectal manometry the median 
resting and squeeze pressures were 57 mmHg and 85 mmHg respectively, and remained constant 
over time. The therapeutic response threshold was significantly lower than the sensitivity 
threshold (median 1.6 vs. 1.7 V; P=0.042). The median motor threshold was 2.1 V, significantly 
higher than the sensitivity threshold (P=0.009). The stimulation threshold for suboptimal 
therapeutic response was 1.4 Volts. In five of the eight patients the therapeutic response threshold 
was the same as the sensitivity threshold. 
 
CONCLUSION 
SNM can produce a therapeutic effect below the sensitivity threshold. A lower stimulation 
voltage increases the lifespan of the pulse generator. 
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INTRODUCTION 
Faecal continence is maintained by a combination of physiological 
parameters, including functioning anal sphincters, coordinated recto-
sigmoid perception and motility, and solid-consistency stool.1 
Incontinence may occur when one or more of these factors alter.  
Surgery is necessary when conservative treatment gives unsatisfactory 
results. 
A high success rate is observed in patients with a simple structural defect 
of the external anal sphincter that can be corrected surgically. However, 
some patients with an internal anal sphincter muscle defect or a weak, but 
structurally intact external anal sphincter do not benefit from simple 
surgical procedures.1,2 For these patients therapeutic electrostimulation of 
the sacral nerves by sacral nerve modulation (SNM) is the treatment of 
choice. 
SNM has been used to treat urinary incontinence and urine retention,3-5 
and has also proven to be a successful treatment for faecal 
incontinence.6,7 The procedure is performed in three stages.1,8 
Percutaneous neural evaluation (PNE) is first performed to assess the 
effect of SNM. An electrode is then inserted and a test stimulation is 
performed over a three-week period. If this test stimulation produces a 
decrease in incontinence episodes of more than 50%, a permanent 
electrode, extension cable and pulse generator is implanted. A minimal 
continuous tingling sensation in the anus, labia or pelvic floor indicates 
that the stimulation is working. This sensation is continuous during the 
first few weeks after implantation, but after 4-6 weeks it occurs only 
shortly after reactivating the pulse generator. During the first 2-3 months 
the voltage requires adjustment, after which it remains stable.7 The 
mechanism underlying the effect of SNM has not been clarified but 
probably involves both motor and sensory pathways.8 This study 
investigated whether the perineal sensation is essential for a therapeutic 
effect. 
PATIENTS AND METHODS 
Patients with a successful permanent implantation for SNM and a 
minimum follow-up of three months were included. The SNM procedure 
has been described previously.6,8,9 All patients had undergone 
preoperative investigations including anorectal manometry with rectal 
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balloon dilatation, defaecography, endoanal ultrasonography and 
determination of pudendal nerve motor latency times. 
Inclusion criteria were a structurally intact external anal sphincter 
confirmed by endoanal ultrasonography and faecal incontinence with a 
frequency of more than once a week. Exclusion criteria were congenital 
anorectal malformations, rectal surgery in the preceding 12 months or 
inflammatory skin disease around the sacrum.  
The lowest voltage at which the tingling sensation was present around the 
anus, at the perineum, pelvic floor or labia (in women) or scrotum (in 
men) determined the best pulse generator setting.8 This voltage is called 
the sensitivity threshold (ST). Sensation at the sacrum, buttock or glans 
penis was not accepted. To determine the motor threshold (MT), the 
electrode setting was maintained and the voltage was increased to the 
lowest level at which a motor response of the anal sphincter was present. 
In all patients the ST was lower than the MT. Patients went home with 
the voltage set at 0.6 V below the ST. Each week the voltage was 
increased by an increment of 0.2 V until the ST was reached. During 
these four weeks a bowel movement diary was completed. The optimal 
therapeutic response threshold (TT) was determined. A suboptimal 
therapeutic response threshold (STT) was a voltage at which an 
improvement in continence was observed, but not an optimal 
improvement. The definition for suboptimal improvement was either a 
strong urge to defaecate, which was not present during treatment with 
SNM before the study; or a decreased effect of SNM, but still more than 
50% improvement in comparison to incontinence episodes before SNM 
implantation. The therapeutic response threshold was the voltage that 
produced the optimal effect of SNM. The baseline for optimum was 
determined according to the result achieved during the preceding 
treatment with SNM. 
Statistical analysis was performed using the Wilcoxon and Mann-
Whitney U tests for non-parametric samples in SPSS 11.0 (SPSS, 
Chicago, Illinois, USA). Results are presented as median (range). 
Statistical significance was set at P≤0.050. 
RESULTS 
Eight patients (seven women) with a median age of 58.5 (32.5-66.6) 
years were studied. Median follow-up was 6.3 (3.2-13.5) months. The 
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median duration of incontinence before SNM was 7.5 (range 2.0-61.0) 
years. The aetiology was idiopathic in five patients.  
Two patients had a pudendal neuropathy, two had had a hysterectomy 
and two an obstetric injury. Two other patients had a history of a nucleus 
pulposus herniation, and one patient had undergone an anal repair and a 
hysterectomy. 
The median sensibility threshold volume of rectal sensation was 50 
(30-150) ml. The median urge threshold volume was 140 (90-400) ml 
and the median maximum tolerated rectal volume was 240 (150-400) ml. 
The number of incontinence episodes per week and number of days 
affected by incontinence per week decreased with stimulation 
(Figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Number of incontinence episodes and days affected by incontinence per week, 
before (baseline) and after implantation with sacral nerve modulation. Horizontal 
bars, boxes and error bars represent median, interquartile range and range 
respectively. 
 
 
 
 
 
baseline     teststimulation 1 month      3 months        6 months      12 months
No. of patients  8                      8                    8 8 6 4
9
8
7
6
5
4
3
2
1
0
incontinence days
incontinence episodes
Thesis_Lansen_Koch_v5.pdf   75 16-4-2009   11:21:29
   76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Resting and squeeze pressures before (baseline) and after implantation with sacral 
nerve modulation. Horizontal bars, boxes and error bars represent median, 
interquartile range and range respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Suboptimal therapeutic response threshold (STT), therapeutic response threshold 
(TT), sensitivity threshold (ST) and motoric threshold (MT). Horizontal bars, boxes 
and error bars represent median, interquartile range and range respectively. 
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Figure 4.4 Number of incontinence episodes per week recorded before implantation with SNM 
(baseline), and during week 1 (0.6 Volts below sensitivity threshold), week 2 (0.4 
Volts below sensitivity threshold, week 3 (0.2 Volts below sensitivity threshold) and 
week 4 (stimulation at sensitivity threshold). 
 
 
Resting and squeeze anal canal pressures remained constant over time 
(Figure 4.2). The TT was significantly lower than the ST (median 1.6 
(0.9-2.9) vs. 1.7 (0.9-2.9)V; P=0.042). The MT (median 2.1 (1.2-3.1)V) 
was significantly higher than the ST (P=0.009). The STT was 1.4 
(1.3-1.4) V (Figure 4.3). In five of eight patients the TT was the same as 
the ST, including both patients with pudendal neuropathy.  Examination 
of the diaries revealed a gradual decrease in incontinence episodes over 
the four weeks during which the stimulation voltage was increased 
(Figure 4.4). 
DISCUSSION 
The mechanism underlying the functional improvement provided by 
SNM is still unknown. It was originally suggested that SNM improved 
continence by stimulating and strengthening the anal sphincter. In two 
studies by Ganio et al.10,11 stimulation was noted to increase both resting 
and squeeze pressures. Other studies reported only increased squeeze 
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pressures,1,6,7,12 and Ganio et al.9 reported an increase in resting pressure 
only in another study. Rosen and al. demonstrated increased squeeze and 
resting pressures in patients with neurogenic incontinence but no increase 
in patients with idiopathic incontinence.13 Other studies have found no 
significant improvement in resting and squeeze pressures,8,14-16 probably 
because the stimulation voltage applied to achieve a therapeutic effect 
was low. An analysis of all studies has revealed that those reporting 
increased resting and/or squeeze pressures used a maximum stimulation 
amplitude that was comfortable to the patient1,9,11 or stimulation adapted 
according to the patients’ perception of muscular contraction.6 Studies 
that did not report increased anal pressures used stimulation voltages just 
above sensitivity threshold16 and stimulation voltages adjusted to fine 
tune continence.15 Only one study that did not find increased anal 
pressures reported a stimulation voltage adapted according to the 
patients’ perception of muscular contraction.14 Voltage data are only 
available for a few studies and therefore comparison is difficult. 
However, a stimulation voltage below the motor threshold is apparently 
sufficient to induce a therapeutic effect. 
In the present study the MT was shown to be higher than the ST. 
Continuous stimulation at the level of the MT probably induces a 
transformation of type II fatigue-prone to type I fatigue-resistant muscle 
fibres. This phenomenon is also observed in dynamic graciloplasty, that 
increases the duration of the contraction and/or anal canal pressures.17 
However, rectal sensitivity and activity, and pelvic floor coordination are 
just as important in maintaining continence as functioning anal 
sphincters.1 Stimulation at the level of the ST or below probably results 
in a better motor and sensory input and output of the rectum. For this 
reason the term sacral nerve modulation is preferred over sacral nerve 
stimulation.  
The pelvic floor and anal sphincters receive motor innervation from S2-4. 
Direct branches of the sacral plexuses, but mostly S3, innervate the 
levator ani and puborectal muscles. S3 stimulation causes contraction of 
the pelvic floor musculature, which might slightly raise the anal canal 
pressure, but primarily decreases the recto anal angle.18 The maximal rise 
in anal canal pressure is induced via stimulation of the pudendal nerve. 
The pudendal nerve derives mainly from S2, although S3 may contribute 
to varying degrees. 
The external anal sphincter contracts voluntarily, but also by reflex 
action. Reflex contraction is due to a sacral reflex arc.8 The Aδ fibres of 
the sacral plexus are probably stimulated with SNM, and modulate sacral 
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reflexes. In this way the sacral reflex arc is altered by SNM.1 The effects 
of stimulation are likely to be more diverse than a simple effect on the 
efferent motor supply of the sphincter.1 The internal anal sphincter is 
innervated by the sympathetic (hypogastric plexus) and parasympathetic 
autonomic pathways. Only a few studies report increased resting and 
squeeze anal canal pressures with SNM.10,11 The level of stimulation 
required to achieve smooth muscle contraction via autonomic myelinated 
efferent fibres is three to five times higher than the threshold for α-motor 
neurons, which innervate the striated muscle fibres of the external anal 
sphincter. 
In a mixed nerve the largest fibres are the IA sensory fibres that respond 
to phasic muscle stretch; these are also the fibres with the lowest 
stimulation threshold. The mixed nerves modulate the sacral reflexes. 
The α-motor neurons need a higher level of stimulation than the IA 
sensory fibres. The level of stimulation required to activate afferent Aδ 
fibres is 1.5 times higher than that for the α-motor neurons.1 
Chronic low-grade stimulation at the sensory threshold or lower causes 
an insufficient stimulus to raise anal sphincter pressure, but the stimulus 
may be enough to modulate the Aδ reflexes and IA sensory fibres. 
Modulation of sacral reflexes that serve the rectum may stabilize rectal 
contractile activity and improve rectal sensation.8,13,16,18-20 Several studies 
support this theory. Voluntary motor pathways involved in pelvic floor 
control originate in the most medial part of the primary motor cortex, the 
medial cerebellum and the motor thalamus.21 One study provided 
evidence for a supraspinally mediated site of modulation by SNM, most 
probably in the sensory cortex.22 
The present study has shown that it is possible to obtain a therapeutic 
result with stimulation below the ST. This observation supports the 
hypothesis that the effects of SNM on incontinence are not merely 
explained by motor responses, but probably involve modulation of 
sensory responses of the sacral nerve plexus. However, most patients 
prefer to feel the stimulation because this confirms that the stimulator is 
working. Stimulating below the ST should extend the life of the pulse 
generator. There are currently no data on the lifespan of pulse generators 
in patients with SNM because the follow-up is still too short, but that of 
pulse generators in patients with a dynamic graciloplasty was reported to 
be 7.8 years.23 Pulse generator used for SNM should last longer, because 
the stimulator may be turned off at night, as during sleep involuntary 
faecal loss is rare. 
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ABSTRACT 
PURPOSE 
Sacral Nerve Modulation (SNM) is a well accepted method for the treatment of defaecation and 
voiding disorders. Results vary and depend on the underlying disease. Results of SNM in patients 
with spinal cord lesions are not well assessed, but preliminary results look poor. Therefore, the 
purpose of this study was to assess the use of SNM in patients with spina bifida and defaecation 
and micturition disorders. 
 
PATIENTS AND METHODS 
Consecutive patients with spina bifida suffering from a myelomeningocele and combined 
defaecation and voiding disorders that were tested with a peripheral nerve evaluation were 
included in the study.  
Patient history and medication was noted and diagnostics were performed. A peripheral nerve 
evaluation was performed and when successful followed by a test stimulation for a period of three 
weeks. A permanent implantation was performed after successful test stimulation. Follow-up data 
including anorectal manometry and rectal balloon insufflation were scheduled at one, three, six 
and 12 months. 
 
RESULTS 
Between February 2003 and December 2006, ten patients (four females) were included in this 
study with a median age of 26.4 years. In two patients the peripheral nerve evaluation was 
unsuccessful and consequently eight patients underwent a test stimulation. The median 
incontinence days and episodes per three weeks decreased significantly during test stimulation 
(P=0.033), but only three of ten (30%) patients had a more than 50% improvement and proceeded 
to SNM implantation. All patients had a malformed sacrum. Patients with an absent pudendal 
nerve terminal motor latency times were technically more difficult to stimulate, but successful 
peripheral nerve evaluation and/or test stimulation was not excluded in these patients. 
 
CONCLUSION 
SNM can be successful in a subgroup of spina bifida patients with combined defaecation and 
voiding disorders. 
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INTRODUCTION 
The affected spinal cord in spina bifida patients suffering from a 
myelomeningocele (SB) may lead to profound motor, sensory and 
autonomic disorders in the lower limbs, bladder and bowel, depending on 
the level and the pattern of the cord lesion.1 
Faecal incontinence, constipation, urinary incontinence and retention are 
major impairments affecting the quality of life and social integration of 
patients with SB.2 Lack of bowel control is found to be as stressful as 
bladder dysfunction and even more stressful as the impairment of motor 
function.3 Several studies report successful treatment of defaecation and 
voiding disorders with sacral nerve modulation (SNM). But only a few 
reports about the use of SNM in SB patients exist in the literature and 
preliminary results look poor.4-9  
The purpose of this study was to assess the effectiveness of SNM for the 
treatment of combined defaecation and voiding disorders in patients with 
SB. Also selection criteria for successful result of SNM in SB patients 
were assessed. 
PATIENTS AND METHODS 
Patients 
Consecutive SB patients with combined defaecation and micturition 
disorders who were tested with a PNE were included in the study. 
Inclusion criteria were age above eight years, not or only partially 
wheelchair bound, a structurally intact external anal sphincter and failed 
conservative therapy including colonic irrigation. Exclusion criteria were 
severe grade III/IV pelvic prolapse, rectal prolapse, cystocele, 
urethrocele, enterocele, rectocele, chronic inflammatory bowel diseases, 
chronic diarrhoea, anatomic obstructive voiding disorders and stress 
incontinence for urine. 
Patients completed a baseline defaecation diary during three weeks. 
Faecal incontinence was defined as incontinence for solid or liquid stool 
more than once a week on average. Constipation was defined as less than 
two bowel movements per week, difficulty in emptying the rectum or 
feeling of incomplete evacuation for more than 50% of the bowel 
movements during the previous year. Urinary incontinence was defined 
as incontinence associated with or without overactive detrusor function 
during cystometric evaluation. Urinary retention or voiding dysfunction 
Thesis_Lansen_Koch_v5.pdf   85 16-4-2009   11:21:30
   86 
was defined as hesitancy or intermittency due to an acontractile detrusor 
or obstruction due to urethral sphincter overactivity resulting in 
incomplete voiding or retention (>100 cc residual).  
Diagnostics 
Information on history and medication was collected and anorectal 
manometry, pudendal nerve terminal motor latency time measurement, 
endo-anal ultrasonography and X-ray of the sacrum were collected. In 
patients having voiding disorders as major complaint a micturition 
cystogram was performed. 
Diagnostic measurements were performed starting with anorectal 
manometry using a four point solid state catheter (Konigsberg instrument 
Inc., Pasadena, CA) measuring resting and squeeze pressures, anal and 
rectal pressures during straining and coughing. The recto-anal inhibitory 
reflex (RAIR) was assessed using this catheter together with a balloon. 
Rectal sensitivity and capacity was assessed with a balloon catheter; 
measurement of first rectal sensation volume (FRSV), first urge sensation 
volume (FUSV) and the maximal tolerated volume (MTV) was 
performed by rectal balloon insufflation. Each patient underwent an 
endo-anal ultrasonography (7.5 MHz, SDD 2000, Multiview, Aloka, 
Japan). Pudendal nerve terminal motor latency times (PNTML) were 
assessed using a St. Marks pudendal electrode (Medtronic USA). 
Pudendopathy was diagnosed in case of a PNTML of >2.4 ms or the 
presence of an abnormal curve. In case of an abnormal curve, the 
PNMTL was recorded as absent. 
Sacral Nerve Modulation 
Patient history and symptoms, results of anorectal and urodynamic 
physiologic testing and a sacral neuromodulation screening period 
determined whether a patient was a candidate for permanent implantation 
with SNM. The first step is the peripheral neural evaluation (PNE) which 
is considered successful in case of a good motoric response, achieved by 
a contraction of the anal sphincter or a plantar flexion of the great toe 
and/or a sensory response characterized by a continuous tingling 
sensation around the anus, pelvic floor, labia or scrotum. Only the 
motoric response was assessed in children, because the PNE was 
performed under general anaesthesia in the paediatric group. An 
electrode was positioned in the foramina of S2 to S4, but preferably in 
the third sacral foramen and connected to an external test stimulator after 
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a successful PNE for a three-week evaluation period (trial screening). 
The test stimulation (TS) period was successful if there was an 
improvement of 50% in one of the defaecation disorders (incontinence 
days or episodes, straining, abdominal pain, bloating abdomen and 
incomplete evacuation) or micturition disorders (spontaneous voiding,  
number of voids, number of urinary leakages and catheterized volume), 
objectivated by a diary. SNM was indicated after successful TS. 
The implantable components of the sacral nerve stimulation system 
(Medtronic®) include an implantable pulse generator (IPG), a connection 
wire and a lead with quadripolar electrodes. The electrode is positioned 
in one of the sacral foramina by an open procedure under general 
anaesthesia, attaching the electrode to the fascia of the sacrum, typically 
at the level of S3. The IPG is implanted subcutaneously in the buttock. 
The physician uses an external programmer to adjust the parameters of 
the electrical stimulation produced by the IPG. The patient uses a hand-
held programmer to turn the IPG on or off.  
Follow-up data were collected at one month, three months, six months, 
12 months postoperatively and yearly thereafter. Anal manometry was 
performed at three, six, and 12 months. Rectal balloon insufflation was 
performed at three and six months. 
Data analysis 
Statistical analysis was performed with SPSS 14.0 (SPSS release 14.0, 
SPSS Inc. Chicago). The Wilcoxon non-parametric test for paired 
samples was used to test the statistical significance of overall SNM 
outcome during follow-up compared to baseline values. Data were 
expressed as median values and range. Statistical significance was set at 
P≤0.050. 
RESULTS 
Baseline 
Ten patients (four females) were included in the study between February 
2003 and December 2006 with a median age of 26.4 (11.1-41.0) years.  
Medical diagnosis, defaecation and micturition disorders are described in 
Table 5.1. The results of anorectal manometry and rectal balloon 
insufflation are shown in Table 5.2. PNMTL was bilaterally normal in 
only one patient, while all other (eight of nine) patients had a 
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pudendopathy; two patients had bilaterally absent PNMTL. In one patient 
PNMTL were not assessed. Endo-anal ultrasound showed ventral atrophy 
of the external anal sphincter in one patient and scarring in another 
patient, other patients had no structural abnormalities. An X-ray showed 
lumbo-sacral anomalies in all patients with gradations from an open 
lamina to a totally abnormal sacrum. 
Sacral nerve modulation 
The PNE was successful in eight of the ten included patients. These eight 
patients subsequently had a TS. The median incontinence days and 
episodes per 21 days during TS decreased from 6.0 (2-19) to 3.5 (1.3-8) 
(P=0.030) and 8.5 (2-35) to 3.5 (1.3-8) (P=0.033) respectively in six 
patients with faecal incontinence. The median defaecation frequency per 
day decreased significantly from 3.5 (1.0-5.0) to 2.0 (0.4-3.0) during TS 
(P=0.022). Three of the total ten included (30%) Patients fulfilled the 
criteria of successful TS and proceeded to SNM implantation. Two 
patients with faecal incontinence improved more than 50%. One patient 
(patient 6) improved from 19.0 to 1.3 incontinence days per 21 days and 
from 35.0 to 1.3 incontinence episodes per 21 days. Another patient 
(patient 9) improved from 7.0 to 2.0 incontinence days per 21 days and 
from 12.0 to 2.0 incontinence episodes per 21 days. The urinary retention 
improved in a third patient (patient 1): spontaneous voiding per day 
improved from 10 ml to 150 ml, the number of voids per day improved 
from 0.2 to 1.3 and the number of urinary leakages per day decreased 
from 0.4 to 0.0. The catheterized volume however did not improve. This 
patient also had constipation: the abdominal pain improved from 24% to 
14% of the days, and bloating abdomen improved from 19% to 5%. The 
percentage of straining and incomplete evacuation did not improve. In 
one patient (patient 6) the implantation was technically impossible, 
because the motoric response was absent under general anaesthesia. A 
tined lead procedure10 under local anaesthesia is planned for this patient.  
Anorectal physiologic testing 
All three patients with successful PNE had a malformed sacrum and 
pudendopathy; one patient had bilaterally absent PNMTL. Two of three 
patients had a normal RAIR baseline. 
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Table 5.1 Patient characteristics.  
Patient Age Medical history Faecal 
incontinence
Constipation Urinary 
incontinence 
Urinary 
retention 
1# 15 Tethered cord - + + + 
2 20 Durasac L5 + + + + 
3 11 Tethered cord - + + - 
4 17 Ileocystoplasty DGP, 
rectovaginal fistula  
+ + - + 
5* 26 Heart operation + - + + 
6# 41 Hydrocephalus, VP drain, 
Indiana pouch 
+ - - + 
7 40 Monokidney, bricker urostomy + + Na Na 
8* 40 Operation spina bifida + + - + 
9# 37 Tethered cord + - - + 
10 27 Tethered cord + + + - 
* No reaction with PNE. # Successful TS 
 
 
Table 5.2 The results of anorectal manometry and rectal balloon distension baseline.  
n=10 Median (range) Normal values 
Resting pressure in mmHg  55 (42-121)  35 - 70 
Squeeze pressure in mmHg  84 (53-144)  140 - 220 
Anal pressure during coughing in mmHg  109 (63-175) anal pressure > rectal pressure 
Rectal pressures during coughing in mmHg 90 (57-119) anal pressure > rectal pressure 
Anal pressures during straining in mmHg  81 (60-193) anal pressure < rectal pressure 
Rectal pressures during straining in mmHg  97 (71-179) anal pressure < rectal pressure 
   
RAIR present in 7/10 patients  
   
FRSV in ml  88 (10-240)  10 - 30 
FUSV in ml  125 (30-380)  60 - 150 
MTV in ml  190 (75-400)  150 - 250 
RAIR, recto-anal inhibition reflex; FRSV, first rectal sensation volume; FUSV, first urge 
sensation volume; MTV, maximal tolerable volume. 
 
 
Results of anal manometry and rectal balloon insufflation in the two 
implanted patients did not significantly change during follow-up and are 
shown in Figure 5.1 and 5.2.  
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Figure 5.1 The result of anal manometry (mmHg) in the two patients with successful 
implantation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 The result of rectal sensitivity and capacity (ml) in the two patients with successful 
implantation. 
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Complications 
Patient 9 had an erosion of the pacemaker in the buttock and had his 
pacemaker replaced to the abdomen. 
DISCUSSION 
Treatment of SB patients 
The treatment of defaecation and voiding disorders in SB patients mainly 
consists of conservative therapy; medication to alter consistency of stool, 
diet modification and colonic irrigation in case of faecal incontinence or 
constipation. Anticholinergica, antibiotics in case of associated urinary 
tract infection and intermittent catheterization are used for the treatment 
of micturition disorders.4 Surgical procedures for constipation and faecal 
incontinence in SB patients are usually an Malone antegrade continence 
enema (MACE) using the appendix, caecum, sigmoid or descending 
colon.11 Surgical procedures for urinary incontinence and retention in SB 
patients are peri-urethral injection of bulking agents, bladder neck 
reconstruction, bladder augmentation, and artificial urinary sphincter 
implantation.4 SNM may be an alternative minimally invasive technique 
to treat defaecation and voiding disorders. Another advantage is the test 
stimulation which is performed before proceeding to definitive SNM 
implantation. 
Exclusion criteria 
Patients bound to the wheelchair were excluded from this study. 
Although it is technically possible to treat these patients with surgical 
techniques such as SNM or dynamic graciloplasty, we advise patients 
who are fully wheelchair bound to refrain from these treatment options. 
These treatments usually improve the postponement capacity, but mostly 
not enough for these patients to reach the toilet in a reasonable time and 
make a proper transfer. This patient group is therefore better off with a 
colostomy which deals with the incontinence issue and increases their 
independency. 
Only a few cases of SNM treatment in SB patients are described in the 
literature (Table 5.3).4-9,12 All but one of these studies presents the results 
of a selected SB group. Tanagho reported 27 children with voiding 
dysfunction including 19 children with meningomyelocele.12 Rosen et al. 
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studied a population of 20 patients with faecal incontinence in which two 
patients with SB were included.7 Ganio et al. reported 23 patients with 
various aetiologies, including one patient with SB, having an 
improvement of 50%.13 Holzer et al.6 reported 36 patients with faecal 
incontinence including the 15 patients reported already in the study of 
Rosen et al.,7 of which four patients were SB patients.6 Guys et al. 
performed a study in 21 children with neurogenic bladder dysfunction 
including 13 patients with SB. Enrolment in the study was possible after 
a positive PNE, however the number of patients with unsuccessful PNE 
was not stated. Comparison with other studies including the present study 
is difficult because the criteria for success were not defined in that study.4 
Wallace et al. describe 33 patients with lower urinary tract dysfunction 
and neurological disease, including two patients with SB.5 Pescatori 
reported one patient with SB.9 Jarrett et al.8 report 13 patients with partial 
spinal injury, including one patient with SB.8 In the present study ten SB 
patients were included with combined defaecation and voiding disorders. 
In the entire literature including the present study a total of 53 SB 
patients have been reported. Because the data of Guys et al.4 are not 
available, only 30 patients could be evaluated, resulting in 23 of 40 
patients (58%) with successful TS (Table 5.3). 
Anaesthesia technique 
In this study, the PNE was mostly performed under local anaesthesia 
assessing the sensory and motoric response, except in two children 
(patient 1 and 3). Most studies relied on the motoric response and used 
general anaesthesia.4,6,7 The authors believe a PNE should be performed 
under local anaesthesia, as the patient is aware of the sensation caused by 
the stimulation, whereas under general anaesthesia only the motoric 
response can be assessed. Unpublished data of the authors suggest that 
patients with faecal incontinence and only a sensory response during 
PNE have the same probability of a successful TS and SNM compared to 
patients with (also) a motoric response. This would implicate that a 
potential successful group with only sensory responses are missed when 
PNE is performed under general anaesthesia (unpublished data). The 
implantation however was performed by an open procedure under 
general anaesthesia in all three patients. One of these (patient 6) had no 
motoric response and therefore the system could not be implanted. 
Nevertheless, in cases without motoric response, it is possible to place a 
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percutaneous placed tined lead under local anaesthesia,14 when the sacral 
foramina are intact.   
Technique of implantation 
In case of malformed sacral foramina the authors prefer to perform an 
open procedure to prevent accidental damage to the nerves. In the study 
of Holzer et al., the permanent electrode was sutured directly to the nerve 
by an open procedure.6 Jarrett et al. also reported one patient with an 
absent posterior wall with a migration of the electrode which was 
replaced during an open procedure.8  
 
 
Table 5.3 Review of success percentages and complications in studies treating SB patients 
with SNM. The present study is mentioned under Koch. 
Author n Faecal 
incontinence 
Constipation Urinary 
incontinence
Urinary 
retention
Positive 
PNE 
SuccessComplications 
Tanagho 
1992 12 
19   19  11 11/19 ? 
Rosen 
20017 
  2 2      1 1/2 1 infection 
causing 
explantation  
Ganio 
200113 
  1 1     1   1 1/1 ? 
Guys 
20044 
13 + + 13 13 13 ? ? 
Pescatori 
20049 
  1  1   1    1 1/1 ? 
Jarret 
20058 
  1 1      1 1/1 1 lead migration 
after implantation 
Holzer 
20076 
  4 4 ?   ?    3 3/4 1 infection 
causing 
explantation  
1 lead migration 
after implantation 
Wallace 
20075 
  2     1   1   2 2/2 - 
Koch  10 8 7   5   7   8 3/10 1 erosion of the 
pacemaker 
Total 52     41 23/40  
 
 
Thesis_Lansen_Koch_v5.pdf   93 16-4-2009   11:21:31
   94 
Although all patients had sacral malformations, it was possible to 
stimulate the majority of them. It is important to investigate the caudal 
end of the thecal sac to prevent puncturing the dura, risking meningitis. 
In this study all thecal sacs ended above S2 and whenever in doubt, the 
neurosurgeon was consulted preoperatively.  
Other techniques of electrical stimulation are described in the literature. 
Holmes described six children with SB and faecal soiling with external 
electrical stimulation at S2-S3, achieving continence in three of six 
patients.15 Binnie et al. reported seven patients with spinal cord injury 
and constipation implanted with the Brindley stimulator. After a lumbo-
sacral laminectomy the appropriate anterior sacral nerve roots were 
placed within the electrodes. These patients had a signifant increase in 
the defaecation frequency. This procedure however is complex and 
hazardous for the sacral nerves, and infection of the implant is a major 
threat.16 
Rectal sensitivity 
Constipation and faecal incontinence are common in patients with spina 
bifida affecting about 78%.3,17 Motility is impaired in the distal colon, 
rectal sensation and anal sphincter pressures are reduced.2,18 The present 
study confirms the reduced rectal sensitivity in patients with SB 
(Table 5.2). The results of rectal sensitivity and capacity in different 
studies are shown in Table 5.4. The studies are divided in studies 
including patients with and without neurological disease. The studies 
with neurological disease included patients suffering from various 
neurological congenital or acquired disorders: spinal cord trauma, spinal 
cord surgery, spinal stroke, multiple sclerosis, syringomyelia, SB. The 
FRSV in patients with a neurological disorder is much higher compared 
to other patient groups (Table 5.4).19-24 The FRSV is higher in studies 
that also included patients with neurological disorders,6,7,13 except in a 
study of Jarrett et al., reporting 46 patients including two patients with 
spinal trauma.24 Rosen et al. studied 16 patients, including 14 patients 
with neurological disease.7 Ganio et al. studied 23 patients and included 
ten patients with neurological disease.13 The study of Holzer et al. 
consisted of 36 patients, included 17 patients after spinal cord surgery, 11 
patients with spinal cord trauma and four SB patients.6 In this study, a 
transient decrease in FRSV, FUSV and MTV during SNM was seen. 
Most studies report a decreased FRSV during SNM.7,13,19,21,23-25 A few 
studies report an increased FRSV.6,22,26 FUSV decreased in most 
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studies,6,13,19,21,24,25 but increased in some other studies.22,23,26 The MTV 
decreased in some studies7,19,21,24,25 and increased in other studies.6,22,23,26 
The changes in rectal sensation suggest modification of the afferent 
sensory nerves.21 In conclusion, the results of the different studies are 
controversial and no definitive conclusion can be drawn about rectal 
sensitivity. One may expect decreased FRSV and FUSV and increased 
MTV in these cases where SNM influences rectal sensitivity. 
 
 
Table 5.4 Review of rectal capacity in different studies treating patients with SNM. Volumes 
in ml. All volumes in median and range except for Melenhorst et al. (mean with 
range), Jarrett et al. (mean and SD).  
Author n FRSV 
(normal 10-30ml) 
FUSV 
(normal 60-150ml) 
MTV 
(normal 150-250 ml) 
Neurological disease 
Koch   10 88 125 190 
Rosen 20017   16 90 100 220 
Ganio 200113   23 67 115 - 
Holzer 20076   36 66 110 148 
Jarrett 200424   46 41   92 129 
No neurological disease 
Vaizey 199922   12 45   73   95 
Malouf 200023     5 45   70   95 
Kenefick 200221     5 53   83 143 
Dudding 200820   69 45   81 141 
Melenhorst 200719 100 50 107 175 
FRSV, first rectal sensation volume; FUSV, first urge sensation volume; MTV, maximal tolerable 
volume. 
 
Pudendopathy 
As expected, a high rate of pudendopathy was seen in the present study 
group. It is well-known that pudendopathy is apparent in most patients 
with spinal cord injury.2 Some previous studies showed that patients with 
a bilateral absent PNMTL had no benefit of SNM.13,27 In the studies of 
Ganio et al., successful PNE proved possible in two of three patients with 
spinal cord injury and absent PNMTL. However, the TS failed in these 
patients.13,27 Wallace et al. reported that the outcome of PNMTL was not 
predictive for success or failure of SNM in patients with neurological 
disease.5 One patient in the present study had bilateral absent PNMTL and 
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nevertheless had a good result on TS. Three patients had an unsuccessful 
PNE; one of these patients had absent PNMTL bilaterally and one patient 
bilaterally pudendopathy. It appears that the probability of successful 
PNE or TS is lower in patients with an absent PNMTL, although success 
is not precluded.  
The authors conclude SNM is successful in a selected group of SB 
patients, but proper selection criteria are missing. Dudding et al. reported 
81 patients with faecal incontinence and observed that only a low 
threshold to obtain a motor response during temporary lead insertion was 
associated with improved outcome of TS.20 Larger prospective studies 
should be performed to determine selection criteria for SNM, especially 
in this population.    
CONCLUSION  
SNM for the treatment of defaecation and voiding disorders may be 
successful in a selected group of SB patients. Further studies are 
warranted to determine the prognostic factors for success. 
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ABSTRACT 
PURPOSE 
The aim of this study was to compare long-term results for patients born with an anorectal 
malformation and faecal incontinence treated with a dynamic graciloplasty (DGP) with those for 
the total group of patients undergoing a DGP. 
 
PATIENTS AND METHODS 
Consecutive patients with faecal incontinence after surgical treatment of an anorectal 
malformation and treated with a DGP were included in this study. Preoperative assessment was 
performed. Postoperative follow-up consisted of anorectal manometry and registration of 
defaecation frequency, continence scores and postponement time of defaecation. 
 
RESULTS 
Twenty-eight patients with a median age of 25.5 years were included in the study. The median 
follow-up was 4.0 years. A high anorectal malformation was present in 89% of patients. 
Conventional graciloplasty had been previously performed in 36%. All patients were incontinent 
for faeces. Median frequency of defaecation was 4.0 times/day. Median postponement time of 
defecation was 0 minutes. Rectoanal inhibition reflex was present in 17% of patients. Median 
preoperative sensory threshold during balloon distention was 30 ml and median maximum urge 
threshold was 165 ml. Satisfactory continence was reached in 35% of patients, however, 7% of 
patients gained this continence score by additional bowel irrigation. Twenty-nine percent of 
patients were incontinent for liquid stool, 36% were incontinent for solid stool. Satisfactory 
continence was achieved in only 18% of patients with a high anorectal malformation, compared 
with 100% in patients with a low anorectal malformation. In the total group of patients with a 
DGP, satisfactory continence was obtained in 76%. The sensitivity threshold in patients with a 
successful DGP was lower than that in patients with a failing DGP (45 vs. 24 ml, P=0.060). When 
we compared median preoperative rectal sensitivity threshold in our study group with that in the 
total patient group with a DGP, statistical difference was established (P=0.008). Postponement 
time (0 vs. 20 min.) and anal squeeze pressure (81 vs. 120 mmHg) increased significantly after 
surgery. Patients with an anorectal malformation had significantly lower resting and stimulation 
pressure than that of the total group of patients, but the difference between resting and stimulation 
pressure in both groups was not significantly different (P=0.330). The difference between resting 
and stimulation pressure was not significantly different between anorectal malformation patients 
with a failing DGP and patients with a successful DGP. Complications were noted in 57% of 
patients. Explantation of the DGP was necessary in 32% of patients, mainly because of infection 
of the implant. 
 
CONCLUSION 
Results of DGP for faecal incontinence are reasonable for this specific group of patients with 
limited treatment options. Despite functional DGP, the results are worse than those for the total 
group of patients with DGP. Rectal sensitivity and type of malformation are prognostic factors for 
outcome and can be used to select patients for treatment with DGP, thereby improving treatment 
outcome. 
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INTRODUCTION 
The incidence of congenital anorectal malformations (ARM) is about 1 in 
5000 live births, with a predominance of male children.1 ARM can be 
divided in low and high anorectal anomalies. Classification is based on 
the level of the blind ending rectal pouch in relation to the levator ani 
musculature.2 High lesions occur in 40% of patients and are characterized 
by the rectal pouch being above the levator muscle and can have a 
connection (fistula) to the vagina, bladder, or prostatic urethra. Rectum 
and internal sphincter are usually absent as is the neurovascular system.3 
Associated malformations are present in 65%.4 In low lesions, the rectum 
and the anal sphincters are normally present. A narrow fistula between 
the anorectal cul-de-sac and nearby skin (scrotal, vulvar, or perineal) is 
often present. In 30% of these cases associated malformations can be 
found.4 
Surgical correction of low ARM results in normal bowel control in 
almost 100% of cases. However, a high percentage of these patients have 
constipation.5 In patients with a high ARM, incontinence varies from 8 to 
46% after abdominoperineal or perineal operations. Mostly, posterior 
sagittal anorecto-plasty as described by Pena is performed.1,6-8  
A significant number of children suffer from faecal incontinence or 
constipation, urinary incontinence, and sexual inadequacy after 
correction of ARM.5 The persistence of functional bowel problems can 
be explained by the somatic and psychological disabilities inherent to the 
congenital bowel anomaly. A different faecal consistency and diminished 
control over flatus in addition to the lack of a normal urge sensation and 
an inadequately functioning sphincter mechanism can interfere with 
sanitary training.4 It is important to teach children adequate defaecation 
behaviour and eventually familiarize them with enemas or colonic 
irrigation.9 When children have diarrhoea they should eat more fibre to 
thicken the faeces.5 
Conventional graciloplasty is the most commonly performed procedure 
in patients with persistent faecal incontinence after abdominoperineal 
operations. Conventional graciloplasty has been used since 1952 in 
children with ARM. However, the gracilis muscle can only contract 
voluntarily and is not able to maintain contraction for more than one 
minute. Therefore, dynamic graciloplasty (DGP) was developed to 
create continuous contraction of the gracilis muscle by electrical 
stimulation.1,3,10-16 Successful DGP improves the independence and 
autonomy of these patients. When the gracilis muscle is used for 
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reconstruction of the anal sphincter, most activities of daily life and even 
sports are possible.3,12 
In this study, long-term results of DGP for treatment of faecal 
incontinence in patients after correction of an ARM were investigated 
and compared with those for the total group of DGP patients. 
PATIENTS AND METHODS 
Included in this study were all consecutive patients, from November 
1986 to February 2001, with faecal incontinence after correction of 
ARM. Age at surgery, type of ARM, associated malformations, and 
incontinence score were recorded. Faecal incontinence was scored 
according to the Williams continence score.17 Preoperative anorectal 
manometry was performed with a Konigsberg® catheter (Konigsberg 
Instrument inc., Pasadena, CA, USA) connected with a polygraph 
(Synectics medical, Stockholm, Sweden). Rectal sensibility was 
measured with rectal balloon dilation.  
The DGP procedure has been previously described in detail.3 In short, the 
gracilis muscle is freed in the upper leg; the neurovascular bundle is left 
intact to keep the gracilis muscle vital. Then the muscle is wrapped 
around the anus. The gracilis muscle is electrically stimulated by two 
intramuscular electrodes, which are connected to a pulse generator (IPG, 
Medtronic®, Minneapolis, MN, USA) in the lower abdomen. The 
stimulation of the gracilis muscle is started four weeks postoperatively. 
The frequency of stimulation is increased gradually over two months to 
get sustained tonic contraction of the gracilis muscle. The stimulation has 
to be turned off by the patient with a remote control or a magnet during 
defaecation. The remote control has some advantages above the magnet 
such as use of a beeping sound, which is heard when it is touched and it 
can be used to increase or decrease the voltage. 
Postoperative follow-up consisted of registration of continence scores, 
defaecation frequency, postponement of defaecation, and anorectal 
manometry. The patient group with ARM was compared with the total 
group of patients with a DGP, a large series of 200 patients.3,18 
Statistic analysis was performed by use of Wilcoxon’s rank-sum test and 
Mann-Whitney U test for non-parametric samples in SPSS 11.0 (SPSS 
Inc., Chicago, IL, USA). Statistical significance was set at P≤0.050. Data 
are expressed as median values and range. 
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grade I:   continent
grade II:   incontinent for flatus
grade III:  incontinent for diarrhea
grade IV: incontinent for normal stools
grade V:  totally incontinent
RESULTS 
Twenty-eight patients (83% male) with a median age of 25.5 years 
(12.4-49.1) were included. The median follow-up was 4.0 (0.2-15.5) 
years. All patients underwent surgical correction of ARM after birth. A 
high ARM was present in 25 of 28 (89%) patients. In 52% (13) of these 
patients an associated malformation was noted – ten patients with 
urogenital, eight patients with skeletal, two patients with intestinal, and 
two patients with miscellaneous malformations.  
The patients with a low ARM did not exhibit any associated 
malformations. 
Twenty-nine percent of patients had previously undergone treatment with 
biofeedback therapy. A conventional graciloplasty has been performed in 
ten of 28 (36%) patients.  
All patients were incontinent for solid stools (Grade 4 or 5, Williams’ 
continence score). Median frequency of defaecation was 4.0 (0.3-23) 
times/day. Median postponement time of defaecation was 0 (0-5) 
minutes. 
 
 
 
 
 
 
                                V 
 
                                                           II 
 
 
                    IV 
 
 
                                       III 
 
 
 
 
 
 
 
Figure 6.1 Postoperative continence scores after dynamic graciloplasty in patients with 
anorectal malformations. 
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Figure 6.2 Comparison of postoperative continence scores in patients with anorectal 
malformations after dynamic graciloplasty (DGP) and the total patient group with 
DGP. 
 
 
The recto-anal inhibition reflex (RAIR) was present in three of 18 (17%) 
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after DGP (Figure 6.1). The continence score remained stable over time. 
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Satisfactory continence was achieved in only 18% of patients with a high 
ARM, compared with 100% in patients with a low ARM. The presence 
of associated malformations was not predictive of outcome in patients 
with a high ARM. 
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Fifty-seven percent of patients who had undergone previous treatment 
with biofeedback were continent for stool, compared with 29% of 
patients who had no previous biofeedback therapy. Among patients who 
had undergone previous conventional graciloplasty a continence score of 
1 and 2 was found in 40%, a continence score of 3 in 10%, and Grade 4 
or 5 incontinence in 50%, compared with 33%, 40%, and 27%, 
respectively, in patients who had not previously undergone conventional 
graciloplasty.  
Patients with a successful DGP demonstrated a higher preoperative rectal 
capacity than that of patients with a failed DGP, although this difference 
did not reach statistical significance (236 vs. 163 ml; P=0.180). The 
sensitivity threshold in patients with a successful DGP was lower than 
that in patients with a failing DGP. This difference tended toward 
statistical significance (45 vs. 24 ml; P=0.060). When we compared 
median preoperative rectal sensitivity threshold (30 vs. 40 ml) and 
capacity (165 vs. 150 ml) in our study group with that in the total patients 
group with DGP, statistical difference could be established for sensitivity 
threshold (P=0.008) but not for capacity (P=0.240). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Time of postponement of defaecation for patients with successful dynamic 
graciloplasty and patients with failed dynamic graciloplasty. 
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Additional bowel irrigation with an irrigation pump was used in four of 
28 (14%) patients postoperatively; two of 28 (7%) patients gained 
continence for stools (Grade 1 and 2), whereas the other two of 28 (7%) 
patients were still incontinent for loose stools (Grade 3).  
The median frequency of defaecation postoperatively was 2.0 (0.3-20) 
times/day. 
The median time of postponement was two (0-60) minutes, which was a 
significant improvement compared with the preoperative time of 
postponement (P=0.001). When the time of postponement in patients 
with satisfactory continence (Grade 1 or 2 incontinence) was compared 
with that in patients with a failing DGP (Grade 4 or 5 incontinence), 
median postponement for successful treatment was 20 (1-60) minutes and 
for failing treatment, 0 (0-30) minutes (P=0.009) (Figure 6.3).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Median preoperative and postoperative resting pressures in DGP, stimulation 
pressures after start with electrical stimulation of the graciloplasty. 
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pressure during stimulation was 75 (27-286) mmHg; resting, and 
stimulation pressures in time are shown in Figure 6.4. 
When we compared resting pressure and stimulation pressure in patients 
with successful DGP against the same values for patients with failing 
DGP, the difference in resting pressure was significant (P=0.045), but the 
difference in stimulation pressure was not significant (P=0.150). The 
difference between resting and stimulation pressures was also not 
significant. (P=0.430) (Figure 6.5). When resting and stimulation 
pressures of the ARM patients were compared with values for the total 
group of patients, the patients with ARM had significant lower resting 
pressure and stimulation pressure (P<0.001 vs. P<0.030) (Figure 6.6). 
However, the difference in resting pressure and stimulation pressure 
between both groups was not significantly different (P=0.330). 
Complications were noted in 53% of patients (Table 6.1). Explantation 
of the DGP was necessary in nine of 28 (32%) of the patients, mainly 
because of infection of the implant (18%). Failure of the DGP because of 
insufficient contraction of the gracilis muscle was present in 14% of 
patients, which included patients with an infection of the implant. 
Two other common complications were displacement of the IPG (11%) 
and constipation (7%). 
DISCUSSION 
In this study the results of DGP in patients with ARM were not as good 
as in the total group of patients with faecal incontinence treated with 
DGP (76%);3 35% of all patients gained satisfactory continence. 
Eighteen percent of patients with a high ARM achieved satisfactory 
continence compared with 100% in patients with a low ARM. These 
results can be explained by abnormalities in the neurovascular supply and 
bowel of patients with an ARM. Patients with a high ARM have low 
success rates, probably because a high ARM is accompanied by more 
severe anorectal and/or neurovascular abnormalities. It is well known 
that several anatomic and physiologic entities are essential for 
continence: the anal sphincters, mucosal wall of the anorectum, 
transitional epithelium of the anal canal, rectal capacity, bowel motility, 
anorectal sensitivity for discrimination of its filling and a positive 
RAIR.9  
ARM patients with successful DGP had an almost significantly lower 
sensitivity threshold than patients with failing DGP. Median 
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preoperative sensitivity threshold in the total patient group with DGP was 
significantly lower than that in the ARM patient group. A positive RAIR 
was present in three of 18 (17%) patients. An absent RAIR was not 
related to a failing DGP. Preoperative resting pressure was subnormal as 
was the squeeze pressure. The results in rectal capacity and anal resting 
and squeeze pressures correspond with the results of Hedlund et al.19 
However, our rate of positive RAIR is far lower in comparison to their 
rate (30%).19 Hedlund et al.19 included all patients after a posterior 
sagittal anorectoplasty procedure for ARM.8 The fact that we only 
included the posterior sagittal anorectoplasty failures in our present study 
probably explains the lower rate of positive RAIR. Furthermore, the 
RAIR was not determined in ten patients in the present study.  
This study showed that it was possible to create a higher stimulation 
pressure than resting pressure in all patients-a functional neosphincter. 
The resting and stimulation pressure in the patients with ARM was 
significantly lower than those in the total group, but the difference 
between resting and stimulation pressure was not significant. The same 
difference was present in a comparison between patients with an ARM 
with a successful DGP versus those with a failing DGP. The fact that 
most of the patients did not reach satisfactory continence while the DGP 
was technically functioning well, demonstrates that a functioning 
sphincter is not the sole determinant for faecal continence. The 
multifactorial nature of faecal continence is further reflected by rectal 
sensitivity and type of malformation being prognostic factors for 
outcome in terms of faecal continence after DGP. The worse outcome of 
DGP in patients with a high ARM is explained by the malformed 
neurologic, pelvic and sphincter structures resulting in a lack of normal 
rectal sensation and decreased rectal capacity.3,4   
In this study, 14% of the patients used bowel irrigation with an irrigation 
pump postoperatively and were continent for solid stool (Grade 2 or 3).20 
When patients experience an acceptable social life with the use of 
enemas, colonic irrigation, and medication, results after surgical 
correction of ARM are considerably good or fair.1,9  
Complications were noted in 53% of the patients. However, the most 
serious complication was infection of the implant, requiring explantation. 
Displacement of the IPG (11%) was seen in the first years of the study, 
when the IPG was placed subcutaneously. Thereafter, the IPG was placed 
just under the rectus fascia, which resolved the problem of displacement. 
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Figure 6.5 Median resting and stimulation pressures in anorectal malformation patients with 
successful dynamic graciloplasty and in anorectal malformation patients with a 
failing dynamic graciloplasty. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6 Median resting and stimulation pressures of patients with anorectal malformations 
(ARM) and of total patient group with dynamic graciloplasty. 
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Some patients with anal atresia suffer from constipation in conjunction 
with faecal incontinence. In our study three of 28 (11%) patients suffered 
from constipation preoperatively. Postoperative constipation developed  
in two more patients. This is a common complication after DGP.10 The 
aetiology is not yet elucidated, but it is possible that nervous tissue 
around the anus sustains damage during the operation. It is also plausible 
that constipation is not experienced by patients with faecal incontinence. 
When an adequate closing mechanism (DGP) is performed, the pre-
existing constipation becomes clinically apparent.  
A complication rate of 53% seems high in comparison with a success rate 
of 35%. However, the patients in this group have had other failing 
treatment before. So this is one of the last treatment options before a 
colostomy. 
 
 
Table 6.1 Complication rate.  
Complication Patients n (%) Intervention Number of patients 
Infection implant  5 (18) 5 
Failure contracting gracilis (all 
also infection) 
 4 (14) 
Explantation (1 re-
implant, 1 ABS, 2 
colostomy) 
 
Displacement IPG  3 (11) Subfascial placement 3 
Constipation  2 (7) Colostomy 1 
Displacement lead  2 (7) Revision lead 2 
Prolapse  2 (7) Resection 2 
Pain during stimulation  2 (7) Explantation 1 
Wound-infection  1 (3.6) Antibiotic treatment 1 
Too loose wrap  1 (3.6) Tightening of the 
gracilis 
1 
Wound dehiscence  1 (3.6) Explantation 1 
Total complications  32   
Total patients with 
complications 
 15 (53%)   
ABS, artificial bowel sphincter; IPG, implantable pulse generator. 
 
 
More recent treatment options for faecal incontinence are sacral nerve 
modulation or placement of artificial bowel sphincter (ABS).21-32 
However, sacral nerve modulation is experimental in this patient 
population. Other treatment modalities are a Malone antegrade colonic 
enema or a definitive colostomy.33-35  
Thesis_Lansen_Koch_v5.pdf   112 16-4-2009   11:21:32
   113 
C
hapter 6 
D
ynam
ic G
raciloplasty in anorectal m
alform
ation 
Five patients in this study received an alternative treatment after a failed 
DGP: artificial bowel sphincter (two), colostomy (two) and Malone 
antegrade colonic enema (one). 
CONCLUSION 
Results of DGP for faecal incontinence are reasonable for this specific 
group of patients with limited treatment options. Functional DGP was 
possible in almost all patients but led to continence in only 35%. 
Associated malformations were no determinant for outcome. Rectal 
sensitivity and type of malformation are prognostic factors for outcome 
and can be used to select patients for DGP treatment, thereby improving 
the treatment outcome. 
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ABSTRACT 
PURPOSE 
Dynamic graciloplasty (DGP) improves faecal continence and quality of life for most patients. 
However, in some patients, DGP fails and faecal incontinence is unsolved or only partially 
improved. Constipation is also a significant problem after DGP, occurring in 13-90%. Colonic 
irrigation can be considered as an additional or salvage treatment for defaecation disorders after 
unsuccessful or partially successful DGP. In this study the effectiveness of colonic irrigation for 
the treatment of persistent faecal incontinence and/or constipation after DGP is investigated. 
 
PATIENTS AND METHODS 
Patients with defaecation disorders after DGP visiting the outpatient clinic of the University 
Hospital Maastricht were selected for colonic irrigation as additional therapy or salvage therapy in 
the period between January 1999 and June 2003. The Biotrol® Irrimatic pump or the irrigation 
bag was used for colonic irrigation. Relevant physical and medical history was collected. The 
patients were asked to fill out a detailed questionnaire about colonic irrigation. 
 
RESULTS 
Forty-six patients were included in the study with a mean age of 59.3±12.4 years (80% female). 
On average the patients started the irrigation 21.4±38.8 months after the DGP. Eight patients 
started irrigation before the DGP. Fifty-two percent of the patients used the irrigation as 
additional therapy for faecal incontinence, 24% for constipation and 24% for both. Irrigation was 
usually performed in the morning. The mean frequency of irrigation was 0.90±0.40 times per day. 
The mean amount of water used for the irrigation was 2.27±1.75 litres with a mean duration of 
39±23 minutes.  
Four patients performed antegrade irrigation through a colostomy or appendicostomy, with good 
results. Overall, 81% of the patients were satisfied with the irrigation. Thirty-seven percent of the 
patients with faecal incontinence reached (pseudo)continence and in 30% of the patients the 
constipation completely resolved. Side-effects of the irrigation were reported in 61% of the 
patients: leakage of water after irrigation, abdominal cramps, and distended abdomen. Seven 
(16%) patients stopped the retrograde colonic irrigation. 
 
CONCLUSION 
Colonic irrigation is an effective alternative for the treatment of persistent faecal incontinence 
after DGP and/or recurrent or onset constipation additional to unsuccessful or (partially) 
successful DGP. 
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INTRODUCTION 
Dynamic graciloplasty (DGP) is a proven effective treatment for faecal 
incontinence. Success rates vary from 42-92%.1-5 Comparison of results 
is difficult because the outcome of this method seems to be influenced by 
the aetiology of faecal incontinence, pre-existing stoma, length of follow-
up, method of stimulation and the surgeon’s experience.1,6 DGP 
significantly improves quality of life and faecal continence for most 
patients.2 Quality of life and patient satisfaction scores correlate 
significantly with continence scores.7,8 However, in some patients faecal 
incontinence is unsolved or only partially improved after DGP. 
Morbidity rates are high after DGP: complications associated with the 
technique can often be prevented or treated, but other complications like 
reduced sensitivity of the rectum by destruction of sensory nerves can be 
very hard to treat and often result in DGP failure.4,8,9 Morbidity rates are 
lower and success rates higher in the hands of surgeons experienced in 
the technique.3,10  
Constipation is a significant problem after graciloplasty, occurring in 
13-90% of the patients after DGP.6-8,11,12 Constipation due to technical 
failure, like a gracilis wrap that is too tight, can be treated by revisional 
surgery. Other causes of constipation can first be treated with dietary 
measures and medication. In case of pelvic floor dysfunction, 
biofeedback training can be started.9 When this first line treatment is 
unsuccessful, retrograde colonic irrigation (RCI) can be considered. 
Colonic irrigation can also be used as an additional therapy or salvage 
therapy for persistent faecal incontinence after failed or partially failed 
surgery.13 Not much is known about the success rate of RCI, as there is 
only a limited number of published studies.13,14  
Antegrade irrigation through a colostomy or appendico-caecostomy is 
another technique for colonic irrigation, with a reasonable success rate of 
64-85%.15-17  
In this study, the effectiveness of colonic irrigation for the treatment of 
persistent faecal incontinence and/or constipation after DGP was 
investigated. 
PATIENTS AND METHODS 
Patients with DGP and postoperative defaecation disorders were selected 
for colonic irrigation between January 1999 and June 2003. The patients 
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were offered colonic irrigation as additional or salvage therapy, as a 
colostomy was the final option for these patients. The inclusion criteria 
were invalidating faecal incontinence and/or constipation after DGP and 
a signed informed consent;  exclusion criteria were patients not willing to 
perform the irrigation because of either embarrassment or wish for 
colostomy or patients physically and/or mentally not capable of 
performing irrigation. 
All patients visited the outpatient clinic of the University Hospital 
Maastricht. Relevant physical and medical history was collected. The 
patients could be divided in six groups according to the aetiology of 
faecal incontinence before DGP: congenital, trauma (rupture/anal 
surgery), pudendopathy (PNTML >2.4 ms), spinal cord lesion, cancer 
(abdominoperineal resection in rectal carcinoma), and prolapse. The 
patients were asked to fill out a questionnaire. This questionnaire 
contained questions concerning the method of irrigation, the time needed 
for irrigation, the amount of water used, the frequency of irrigation, 
added substances to the irrigation water and side-effects of colonic 
irrigation. The end-point was defined that irrigation had to be successful 
and satisfying for the patients. Successful irrigation was defined as 
reaching continence for faeces (pseudocontinence) and/or complete 
resolution of straining, feeling of incomplete evacuation, bloating 
abdomen and abdominal pain during irrigation. 
The patient was considered satisfied when he or she indicated that the 
colonic irrigation rendered a major improvement of the quality of life. 
The improvement of quality of life was measured by a visual analogue 
scale/specific questions within the questionnaire. The irrigation was 
performed in most patients as RCI; only four patient performed antegrade 
irrigation through an appendico-caecostomy or a colostomy. Patients 
with faecal incontinence can gain continence as a result of colonic 
irrigation. This is called pseudocontinence, because these patients are 
only continent, as there is no faecal filling of the rectum and distal colon. 
The definition of resolved constipation was no straining and no feeling of 
incomplete evacuation after defaecation. Defaecation occurred during 
irrigation in most of these patients.  
The Biotrol® Irrimatic pump (Braun®) (Figure 7.1A) or the irrigation bag 
(Braun®) (Figure 7.1B) was used for colonic irrigation. The Irrimatic 
pump is an irrigation pump using a flexible tube with a cone-shaped end. 
The tube is introduced either in the anal canal in case of RCI or placed in 
an appendico-caecostomy or colostomy in case of antegrade irrigation. 
The pump can hold a maximum of two litres. The patients were 
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instructed to start the irrigation daily with 500 ml of water. Thereafter, 
the frequency and the amount of water were adjusted until a satisfactory 
result was achieved. Water used for irrigation was at body temperature; 
too cold water can cause abdominal cramps or collapse and too hot water 
can cause burns. Soap or laxatives could be added if necessary. The 
pump works on a storage battery and the speed of water ejection can be 
regulated. The working mechanism of the irrigation bag is similar, except 
for the water ejection, which is induced by gravity. 
Data analysis was performed by using SPSS 14.0 (SPSS release 14.0, 
SPSS Inc. Chicago, USA), with the Mann-Whitney U test. P≤0.050 was 
considered statistically significant. Data are given as the mean values 
with the standard deviation. 
 
RESULTS 
The questionnaire was sent to 74 patients. Fourteen patients did not wish 
to participate in the study for various reasons, and 14 patients did not 
return the questionnaire. Forty-six patients (62%) could be included for 
analysis of which 37 were female (80%), and these patients had an 
overall mean age of 59.3±12.4 years. Complications of the DGP occurred 
in 23 (50%) patients of which ten patients had two or more 
complications. Twenty-two patients suffered from constipation, 35 
patients were still incontinent for faeces and seven patients had pain in 
the IPG pocket, leg or anus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 A. Biotrol® Irrimatic pump (Braun®), B. Irrigation bag (Braun®).  
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The medical history besides the DGP is mentioned in Table 7.1. On 
average the patients started the irrigation 21.4±38.8 months after the 
DGP. Eight patients already used irrigation before DGP. 
Twenty-four (52%) patients used irrigation as an additional therapy for 
faecal incontinence in partially failing DGP. Eleven (24%) patients used 
irrigation for constipation and 11 (24%) patients for both. Most patients 
(91%) used the irrigation pump. Three patients added soap and one 
patient an enema to the water to achieve a better result. These were 
patients with constipation or a combination of faecal incontinence and 
constipation.  
Irrigation was usually performed in the morning (70%) and sometimes in 
the evening (16%). The frequency of irrigation was 0.9±0.4 times per 
day. The amount of water used for irrigation was 2.3±1.8 litres with 
duration of 39±23 minutes. Seventy-four percent of the patients with 
faecal incontinence irrigated in the morning, 17% in the evening and 9% 
twice a day. For the patients with constipation these numbers are 
respectively 45, 18 and 36%. Ninety percent of the patients with a 
combination of defecation disorders used the colonic irrigation in the 
morning.  
There was no significant difference in the frequency of irrigation 
between patients with faecal incontinence and patients with constipation 
(0.9 vs. 1.0/day; P=0.108). The amount of water used for irrigation was 
higher in patients with faecal incontinence compared to patients with 
constipation, but this difference was not significant (2.3 vs. 1.9 l.; 
P=0.484). There was no significant difference in the time needed for 
irrigation between patients with faecal incontinence and those with 
constipation (40.8 vs. 32.9 min.; P=0.154). 
 
 
Table 7.1 Medical history. 
Medical history Number of patients (%) 
Anal rupture during delivery  13 (28%) 
Anal repair  14 (30%) 
Prolapse surgery  19 (41%) 
Hysterectomy  17 (37%) 
Abdominoperineal resection for rectal carcinoma  8 (17%) 
Sigmoid resection for sigmoiditis  2 (9%) 
Cholecystectomy  8 (17%) 
Anus atresia  1 (2%) 
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Overall, 81% of the patients were satisfied with the irrigation; 80% of the 
patients with faecal incontinence, 90% of the patients with constipation 
and 72% of the patients with a combined defaecation disorder. Thirty-
seven percent of the patients with faecal incontinence reached 
(pseudo)continence, and in 30% of the patients the constipation 
completely resolved (Figure 7.2). In 29% of the patients with a 
combined defaecation disorder the constipation resolved and they were 
(pseudo)continent. Overall, satisfaction was related with symptomatic 
improvement. Only one patient with good symptomatic improvement 
was not satisfied because he felt that the irrigation was time-consuming 
and not practical. 
Four patients, two with faecal incontinence, one with constipation and 
one with both, performed antegrade irrigation through a (3) colostomy or 
an (1) appendico-caecostomy with good results and all indicated that the 
irrigation improved their quality of life. 
 
 
                  incontinence                               constipation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 Success of colonic irrigation for defaecation disorders. 
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Table 7.2 Success of colonic irrigation in different aetiologies for faecal incontinence before 
DGP 
Aetiology n Success (%) during irrigation 
Congenital   1  1 (100) 
Trauma  14  3 (21) 
Pudendopathy  16  5 (31) 
Spinal cord lesion   5  3 (60) 
Abdominoperineal resection for rectal carcinoma   8  3 (37) 
Prolapse   2  0 (0) 
Total 46  15 (33) 
 
 
The patients could be divided in six groups according to the underlying 
cause of faecal incontinence before DGP (Table 7.2). When the different 
aetiologies before DGP were compared with the result during irrigation, 
the patients with a rupture or anal surgery had the worst results of 
irrigation. The patients with a spinal cord lesion seemed to have the best 
results. 
Side-effects of the irrigation were reported in 61% of the patients: 
leakage of water after irrigation (43%), abdominal cramps (17%), and 
distended abdomen (17%). Twenty-four (52%) patients changed the 
irrigation method during their course to improve the results. Seven (15%) 
patients stopped the colonic irrigation: in five patients the result was 
unsatisfactory; two other patients did not need the irrigation anymore 
because the complaints resolved completely. Finally, two patients 
received a permanent stoma. 
DISCUSSION 
Colonic irrigation can be used effectively to treat defaecation disorders 
when other conservative treatments fail or in addition to unsuccessful or 
partially successful surgical treatment.18  
Colonic irrigation is usually forgotten as an alternative conservative 
treatment for defaecation disorders, although many health care takers are 
familiar with colonic irrigation, particularly, for its use as peroperative 
colonic cleansing.19,20  
RCI is performed through the anorectum or via a colostomy. Only a few 
publications addressed to RCI are found in literature. Briel et al.13 found 
a success rate of 38% of RCI for faecal incontinence and a significant 
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improvement in quality of life. Recently, another study reported a 
success rate of 41% in patients with faecal incontinence and 65% in 
patients with constipation.18 The success rate is based on patient 
satisfaction. Although patient satisfaction is the primary goal of 
treatment, it is a subjective measure. In future research this should be 
combined with objective measures such as validated quality of life 
questionnaires in a prospective study design. 
Antegrade colonic irrigation is especially known for the treatment of 
evacuation disorders in small children and can be performed through an 
appendico-caecostomy (MACE) or a caecostomy button.16,21-23 
Alternative enteral access is a sigmoid tube or transverse colonic conduit 
for patients with a left colonic evacuation disorder.24-26 The most 
common problems of MACE are stoma stenosis and leakage.16,17 The 
results in our hospital of antegrade irrigation by an appendico-
caecostomy were described earlier.23 In this study four patients 
performed antegrade irrigation via a colostomy or a MACE with good 
results. O’Bichere et al. performed an experimental study investigating 
the effect of retrograde versus antegrade colonic irrigation in pigs. That 
study demonstrates that colonic emptying is more efficient with 
antegrade irrigation compared to RCI.27 Although a reasonable success 
rate can be achieved with antegrade irrigation (64-85%),15-17 RCI is 
preferred above antegrade irrigation as initial treatment because of its 
non-invasive nature and benign complications. 
The amount of water used for irrigation was higher in patients with faecal 
incontinence compared to patients with constipation. This can be 
explained by the difficulty of retaining water in the rectum in case of 
faecal incontinence. Theoretically, the amount of water retained in the 
rectum is higher in patients with constipation. The grade of colonic 
emptying by irrigation in constipated patients by means of scintigraphy 
was investigated by Christensen et al.14 The effect of RCI was 
significantly better in idiopathic faecal incontinence compared to 
idiopathic constipation and its effect correlated with the extent to which 
the irrigation fluid had entered the colorectum.  
Surgical treatment of faecal incontinence gives an overall success of 
50-84%, depending on the aetiology of faecal incontinence and type of 
surgical procedure.28-32 Success percentages in DGP vary from 
42-92%.1-5 The success rate of 80% of colonic irrigation is comparable to 
the success rate of surgical treatment for faecal incontinence. Sixty-one 
percent of the patients that received the questionnaire completed it. Even 
when we assume that the patients who did not complete the questionnaire 
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were dissatisfied with the treatment (bad case scenario), the success rate 
in the present study would still be 50%. It is important to realize that this 
is a selected group of patients with persistent incontinence and/or 
constipation after DGP. Regarding the faecal incontinence, this group of 
patients represents the 8-58% (assuming 42-92% success after DGP) with 
insufficient results of DGP.1-5 
Regarding the different underlying causes for faecal incontinence before 
DGP, the patients with a trauma to the anal sphincter have the lowest 
success rate and the patients with a spinal cord lesion have the highest 
success rate. It is not possible to draw conclusions about the statistical 
significance of these results because of the limited group size. 
Previous studies already reported an increased incidence of constipation 
after DGP.3,6,8,11,12  
In this study we included 22 patients that were constipated after DGP, of 
which 11 patients had constipation in combination with persistent faecal 
incontinence. It is important to realize that many patients are incontinent 
for faeces after periods of severe evacuation problems. These evacuation 
problems are present again after treatment of the faecal incontinence. Its 
aetiology is not well understood, but is likely to be multifactorial.33,34 
This is known after all surgical procedures for faecal incontinence.35 
Constipation can be due to technical problems such as a tight 
graciloplasty, which can be solved by revision of the DGP. It is also 
possible that nerve tissue around the anus sustains damage during the 
operation, causing pudendopathy which cannot be treated by revisional 
surgery. Previous surgery in the pelvis like an abdominoperineal 
resection (eight patients in this study), is known to have a very high rate 
of obstructed defaecation, probably due to reduced rectal sensitivity and 
pelvic floor dysfunction.36 Constipation related to physical impairment, 
like a disturbed sensation and/or motility because of a congenital cause or 
degeneration, is difficult to treat.9 These patients are usually served well 
with colonic irrigation. 
Surgical treatment of constipation is troublesome and only indicated in a 
selected group of patients with intractable constipation. The defaecation 
frequency usually increases, but abdominal pain and bloating persists in 
most patients.37 In this study, 90% of the patients were satisfied with the 
irrigation and in 30%, the constipation resolved with colonic irrigation. 
The final step of treatment after the colonic irrigation in the patients of 
this study would be a colostomy or ileostomy. In the study of Norton et 
al., the majority of the patients with faecal incontinence managed by a 
colostomy reported to be positive about the stoma. However, a few could 
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not adapt to the stoma and disliked it intensely.38 Harris et al. 
investigated patients with faecal incontinence or constipation managed 
with a stoma. Many of these patients reported that lifestyle restrictions 
were imposed by the stoma, and almost half of the patients felt 
stigmatized. Up to a third of these patients had significant depression, 
especially the younger women.39 Cultural issues also have an important 
impact on the acceptance of a stoma.40 Keeping these disadvantages of a 
definitive stoma in mind, colonic irrigation offers an attractive alternative 
which is worthwhile trying before proceeding to a definitive stoma. 
CONCLUSION 
Colonic irrigation is an effective alternative for the treatment of 
persistent faecal incontinence after DGP and/or recurrent or onset 
constipation additional to unsuccessful or (partially) successful DGP. 
Colonic irrigation is an undervalued and often forgotten treatment option, 
which deserves its rightful place among the other treatment modalities. 
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ABSTRACT 
PURPOSE 
To evaluate the therapeutic effect of retrograde colonic irrigation in patients with faecal 
incontinence after a low anterior resection for a rectal carcinoma.  
 
PATIENTS AND METHODS 
Patients with a previous low anterior resection, who were selected for treatment with retrograde 
colonic irrigation for faecal incontinence between 2005 and 2008, were included in the study. The 
data from the patients were gathered by chart research and an interview by phone. 
 
RESULTS 
Thirty patients were included in the study. Three patients died and one patient was not able to 
answer questions due to a cognitive disorder. The data of the remaining 26 patients were 
analysed. Five patients had already stopped with the retrograde colonic irrigation treatment due to 
side-effects. 
Twelve of the 21 patients (57%) who still performed RCI became completely (pseudo)continent, 
three patients (14%) were incontinent for flatus and six patients (29%) were still incontinent for 
liquid stool.  
  
CONCLUSION 
Retrograde colonic irrigation is an effective method to treat patients with faecal incontinence after 
a low anterior resection for rectal carcinoma. Retrograde colonic irrigation is not invasive and has 
only mild side-effects. 
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INTRODUCTION 
A Low Anterior Resection (LAR) combined with preoperative 
radio(chemo)therapy is a frequently used treatment for rectal carcinoma. 
Preoperative radiotherapy has shown to decrease the local recurrence 
rate.1 Also neo-adjuvant chemoradiation in case of a locally advanced 
rectal carcinoma has gained wide acceptance.2 However, up to 40-60% of 
the patients suffer from faecal incontinence after surgery.3-5 Faecal 
incontinence is more likely in patients with a resection less than 6 to 8cm 
from the anal verge. The mechanism is multifactorial.6 This type of 
faecal incontinence is difficult to treat and the outcome of regular 
surgical treatment is poor. The results of Sacral Nerve Modulation 
(SNM), Dynamic Graciloplasty (DGP), and Artificial Bowel Sphincter 
(ABS) are disappointing in this category of patients. A substantial part of 
these patients ends up with a permanent colostomy.7-9 The study of 
Gosselink et al. showed an effective treatment with retrograde colonic 
irrigation (RCI) in 45% of the patients with all kinds of defaecation 
disorders.10 In 1989, Iwama et al. described the use of RCI in a group of 
ten patients with faecal incontinence after LAR.11  
The authors have a wide experience with RCI in clinical practice12,13 and 
observed good results with RCI in patients after LAR for rectal 
carcinoma. The aim of this study was to assess the effect of RCI in 
patients with faecal incontinence after LAR for rectal carcinoma. 
MATERIAL AND METHODS 
A list with all patients who received an irrigation pump for RCI between 
2005 and 2008 was used for this study. Patients for this study were 
selected from this list. Inclusion criteria for this study were faecal 
incontinence after LAR for rectal carcinoma. After informed consent was 
obtained, an interview and a questionnaire were completed with the 
patient by phone. The questionnaire has been used before in two other 
studies.12,13 In this questionnaire, the severity of faecal incontinence was 
assessed using the Williams incontinence scale, ranging from 1, which is 
normal continence, to 5, meaning complete incontinence for solid stool 
(Table 8.1).14 The technique of the irrigation was also assessed: 
frequency of irrigation, time needed for irrigation and the amount of 
water used for the irrigation. The side-effects of RCI were noted. Other 
data were gathered by chart review. 
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The Biotrol® Irrimatic pump (Braun®) was used for RCI. The Irrimatic 
pump is an irrigation pump using a flexible tube with a cone shaped end. 
The cone is introduced in the anal canal. The patients were instructed to 
start the irrigation daily with 500 ml of water. Thereafter, the frequency 
and the volume of water were adjusted until a satisfactory result was 
achieved. Water used for irrigation was at body temperature. The pump 
works on a storage battery and the speed of water ejection can be 
regulated. When the patients went for holidays, most of them temporarily 
used the irrigation bag (Braun®). The working mechanism of the bag is 
similar to the pump, except for the water ejection which is induced by 
gravity.13 When the patient experiences difficulty in keeping the cone in 
place in the anus, it is possible to irrigate with a balloon catheter in the 
rectum. 
Data analysis was performed by using SPSS 14.0 (SPSS release 14.0, 
SPSS Inc. Chicago, USA). For paired variables the Wilcoxon Signed 
ranks test was used. Data are given as the mean values with the standard 
deviation. P≤0.050 was considered statistically significant.  
 
 
Table 8.1 Williams’ incontinence scale.14 
Williams’ score 
Level Gas Liquid stool Solid stool 
I Continent Continent Continent 
II Incontinent Continent Continent 
III Incontinent Occasionally incontinent Continent 
IV Incontinent Frequently incontinent Occasionally incontinent 
V Incontinent Frequently incontinent Frequently incontinent 
 
RESULTS 
Thirty patients were included in the study. Three patients died and one 
patient had too many cognitive problems to answer the questions. 
Twenty-six patients (21 men, 81%) with a mean age of 67.6±7.4 years 
were available for data analysis. The classification of the rectal 
carcinoma was T1-3N0-2 M0. The mean follow-up was 4.7±3.5 years after 
LAR. Patients started RCI 1.6±1.1 years before entering this study. Thus, 
the mean time between LAR and the start of RCI was 3.1±3.1 years. The 
mean Williams’ score before RCI was 4.4±0.7. Most patients (18) 
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reported to have liquid stools, three patients had hard stools, three 
patients had a normal faecal consistency, and two patients had varying 
faecal consistency. The frequency of defaecation was continuous in nine 
patients, 15-20 times/day in four patients, 10-15 times/day in six patients, 
5-10 times/day in four patients, and <5 times/day in three patients.  
Patients performed the irrigation usually in the morning (73%). The 
reason for performing the RCI in the evening was mostly related to work. 
The volume of water used for RCI was 1.5±0.6 litres, with a frequency of 
1.8±0.7 times/day. The time needed for the inflow of water was 7.3±5.5 
minutes, the total time needed for irrigation and defecation was 
43.9±27.3 minutes. 
Fourteen patients (54%) changed their irrigation process during the 
treatment. Seven patients decreased the frequency of irrigation because 
the continence improved. One patient reduced the volume of water used 
for RCI and one patient increased the frequency of irrigation resulting in 
a better effect. Five patients (19%) discontinued the irrigation: one 
patient because the faecal continence improved and RCI was no longer 
necessary. The other four patients were not satisfied with RCI. One of 
these patients received an end-colostomy. In most cases, the result of RCI 
was satisfactory, but the irrigation was found to be too time-consuming, 
not practical or painful.  
The 21 patients who still performed the RCI had a significant 
improvement of the Williams’ score from 4.5±0.6 to 1.7±0.9 (P<0.0001). 
Twelve patients (57%) were (pseudo)continent, three patients (14%) 
were incontinent for flatus and six patients (29%) were incontinent for 
liquid stools (Figure 8.1). They all used pads or a small inlay. Three 
patients (14%) used loperamide on occasion. 
One or more side-effects were experienced by 16 of 26 patients (62%): 
seven patients had abdominal cramps, six patients had leakage after the 
irrigation and two patients felt the irrigation was too time-consuming. 
Eight patients had other side-effects, varying from pain when inserting 
the cone to nausea. 
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Figure 8.1 Scatter/dot chart presenting faecal incontinence expressed in the Williams’ 
incontinence scale14 in 21 patients before and during RCI. * P<0.0001 
 
DISCUSSION 
Faecal incontinence is a major problem for many patients. The lack of 
ability to withhold stool is experienced as very invalidating.15 The cause 
of faecal incontinence after LAR is multifactorial; probably caused by 
loss of the rectal reservoir, by iatrogenic lesions of the anal sphincter or 
damage to the autonomic nerves. Pietsch et al. showed a significant 
reduction of resting and squeeze pressures in patients after a LAR caused 
by innervation problems and fibrosis.16 Intractable diarrhoea after LAR 
can contribute to the faecal incontinence, as also seen in this group of 
patients. 
Binkley described the use of colonic irrigation already in 1952.17 In 1989, 
as mentioned earlier, the use of colonic irrigation was described in 
patients with faecal incontinence after a LAR.11  
Different other conservative and surgical treatments have been used for 
faecal incontinence after LAR for rectal carcinoma. A recent study 
investigated the effect of PFR in this patient group and reported 
improvement in some patients.18 Ratto et al. used SNM for the treatment 
of faecal incontinence following LAR for rectal carcinoma in four 
patients with successful results in all patients during the test stimulation, 
and successful result in three patients after implantation.6 Jarrett et al. 
reported three patients with SNM after a LAR for rectal carcinoma, but 
only two had a successful result of a test stimulation of ten days and after 
*
*
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implantation.19 Melenhorst et al. reported SNM in three patients with 
LAR for rectal carcinoma, nevertheless without a successful result of the 
test stimulation.7 Holzer et al. reported treatment with SNM for faecal 
incontinence after LAR in a retrospective study of seven patients. The 
indication for LAR was rectal carcinoma in six patients and one patient 
suffered from Crohn’s disease. They found promising results during the 
test stimulation in all patients and after implantation with SNM in six 
patients.20 Matzel et al. reported one patient with SNM after LAR for 
rectal carcinoma. Unilateral stimulation after implantation was 
unsatisfactory, but bilateral stimulation resulted in successful outcome. 
Their conclusion was that the effect of SNM on rectal motility, mediated 
by sacral reflex arcs is not likely, because in this patient with LAR a 
denervation of the neorectum must be presumed.21 Holzer et al. and Ratto 
et al. noted a change in neo-rectal parameters during SNM.6,20 Thus, 
SNM is successful in a selected group of patients after LAR with a 
neurogenic impairment. Therefore, proper selection is important.6 Results 
of sphincter replacements techniques for the treatment of faecal 
incontinence after LAR, like the DGP or ABS, have never been described 
in the literature. In patients after abdominoperineal resection the DGP 
can be considered after an abdominoperineal pull through.22 However, 
many of these patients regain only pseudocontinence with the addition of 
RCI.13 Theoretically, as in patients with anal atresia,23 it is probable this 
techniques will not give satisfying results. The sphincter apparatus is 
anatomically intact in these patients, except for some decreased 
function.16 Especially, the rectal sensitivity and capacity is impaired, so a 
sphincter replacement is not logical in these patients. In some patients a 
colonic J pouch is performed to create a neo-rectum. This leads to better 
bowel function and similar rates of postoperative complications in 
comparison to the straight coloanal anastomosis. The side-to-end 
anastomosis, with its ease of construction, is a good alternative to the 
colonic J pouch. It has similar functional outcomes in four randomized 
trials, but further investigation is necessary.24 In the present study, the 
authors had no information about the type and level of the anastomosis.  
The average delay between LAR and start of the RCI was 3.1 years in 
this study. Many of these patients suffered unnecessarily during this 
period. The irrigation pump is largely underutilized, because health care 
workers are usually not informed about this treatment option or because 
they assume that RCI is too time-consuming.25 In this study population 
the mean time needed for RCI was 43.9 minutes. All but five of the 
patients took the required time and experienced side-effects as 
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acceptable. Patients pointed out that prior to RCI they did not dare to 
move out of the house, they could not work and their social contacts were 
lost. The care related to their faecal incontinence also took a lot of time. 
The use of RCI improved their quality of life; they started to work again 
and took part in social activities. 
One of the side-effects is that the patients experience difficulty in 
keeping the cone in place in the anus. It is possible to irrigate with a 
balloon catheter in this situation. There is also a possibility to use 
antegrade irrigation through an appendicostomy, a Malone Antegrade 
Colonic Enema (MACE). This is more effective compared to retrograde 
irrigation, but this treatment also causes more serious complications.26,27 
When patients are not satisfied with the irrigation, the choice for a 
permanent colostomy remains available. Although the ultra-low 
anastomosis has been partially associated with functional problems like 
faecal incontinence and sexual dysfunction, it is widely accepted that 
patients have a significantly better quality of life without a permanent 
colostomy.28,29 
In these kinds of studies, the subjective experience of patients is used as 
the most important outcome measure. The severity of incontinence can 
be assessed by validated scores, but eventually it is the subjective 
experience of the patients that matters the most and is used as outcome 
measure. A prospective study is necessary with anorectal manometry, 
rectal sensitivity and capacity measurements to gain more mechanistic 
insight and to confirm the results of the present study.  
CONCLUSION 
RCI is an effective treatment for patients with faecal incontinence after 
LAR for rectum carcinoma. A large group of patients can be treated with 
this relatively cheap and simple treatment, without major side-effects. 
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COLONIC AND ANORECTAL FUNCTION TESTS 
The anorectal function and anatomy is assessed before the decision for a 
certain treatment is made. Table 9.1 shows the different tests and their 
use in daily practice in different hospitals in the Netherlands for 
evaluation in patients with faecal incontinence.1 
 
 
Table 9.1 Different investigations to assess colonic and anorectal function. Percentages of 
Dutch hospitals that use the different investigations in the work-up of patients with 
faecal incontinence.1 
Investigation Function assessed Information provided Use in 
hospital1 
Anorectal 
manometry 
Resting and squeeze pressures 
Pressures during straining and 
coughing 
RAIR 
Anal sphincter function 
Pelvic floor function 
Rectal nerve supply 
51% 
Rectal balloon 
dilation 
RAIR 
Rectal sensitivity and capacity 
Hyposensitivity  
Hypersensitivity 
22% 
PNTML Pudendal nerve function Pudendopathy 20% 
Endo-anal 
ultrasound 
Imaging of anorectum 
 
Imaging of IAS en EAS and 
puborectalis and assessment 
of integrity and degeneration 
Detection of tumour, fistulas 
58% 
Defaecography Dynamic assessment of 
anorectum 
Continence 
Retention 
Anorectal angle 
Pelvic floor function 
Recto-enterocele 
Intussusception 
Rectal prolapse 
56% 
MRI Anorectal anatomy Imaging of IAS, EAS and 
puborectalis and assessment 
of integrity and degeneration 
Tumours 
Fistulas 
13% 
Antroduodenal 
manometry18 
 
Gastric peristalsis 
Small bowel peristalsis 
Gastric dysmotility 
Small bowel dysmotility 
Chronic pseudo-obstruction 
syndrome 
Chronic intestinal pseudo-
obstruction 
 
Colonic transit 
times  
Colonic transit time  Segmental colon denervation 
Pelvic outlet obstruction 
Total slow-transit colon  
 
Sigmoidoscopy
+biopsy 
Visualisation rectosigmoid Tumour 
Proctitis 
Colitis 
Hirschsprung 
64% 
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A relation of clinical presentation of faecal incontinence to abnormalities 
of anorectal physiology or anatomy is hypothesized in several studies. 
Colorectal function is very important in cases of constipation,2 and can 
facilitate the work-up of patients with faecal incontinence and 
constipation.3,4 Anal inspection and digital rectal examination can give 
information about internal and external sphincter function but are 
inaccurate for sphincter defects less than 90 degrees.5 Also other 
abnormalities like rectal prolapse can be assessed,2 and anal or rectal 
carcinoma can be detected. Colorectal and anorectal function tests are 
performed to assess the aetiology of defaecation disorders. However, 
there is overlap with normal controls, especially in faecal incontinence.6,7  
Anorectal manometry gives accurate information about anal sphincter 
function, but does not differentiate between traumatic sphincter damage 
or atrophy.2 Incontinent patients have lower resting and squeeze 
pressures compared to continent patients.6,7 Tjandra et al. reported lower 
resting and squeeze pressures in patients suffering from defaecation 
disorders with spinal cord injury, however some of them overlapped with 
the normal range.8 Significant lower resting and squeeze pressures were 
correlated with passive incontinence compared to patients with urge 
incontinence in the study of Deutekom et al. Patients had resting 
pressures and squeeze pressures below normal in 29% and 75% 
respectively, so the other patients had normal pressures.4 Molnar et al. 
reported higher resting and squeeze pressures in children with soiling or 
constipation in comparison to controls.9 Paradoxically, increased anal 
pressure during straining is readily detected in patients with pelvic floor 
dyssynergia, a common cause of constipation.10 
The recto-anal inhibition reflex (RAIR) is assessed by balloon 
insufflation in the rectum followed by a decrease of the resting pressure 
of 10 mmHg. Tjandra et al. reported an absent RAIR in patients with 
spinal cord injury.8 In patients with anal atresia the RAIR is absent in 
most patients.11  
Rectal balloon distension measurement can be performed by rectal 
balloon insufflation or a barostat system.2 In this thesis, the rectal balloon 
insufflation was used, because of easier clinical practice and planning. 
The advantage of barostat above the rectal balloon insufflation is that the 
rectal wall tension can be measured with a non-elastic bag delivering 
constant pressures, giving a measure of rectal compliance.12 
With the rectal balloon distension measurement, first rectal sensation 
volume, first urge sensation volume and the maximal tolerated volume 
can be determined. It is known that the type of inflation (phasic vs. 
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continuous), the speed of continuous inflation and additionally the size 
and shape of the balloon affects the first rectal sensation volume.2 In this 
thesis, rectal balloon insufflation with phasic inflation of 50ml or air with 
a syringe was performed. In incontinent patients the maximal tolerated 
volume is lower.6 Constipated patients have a higher rectal sensitivity 
threshold, which signifies a decreased rectal sensitivity.9,13 In patients 
with congenital anorectal disorders, like anal atresia or spina bifida, the 
rectal sensation is mostly decreased.8,14 
Endo-anal ultrasonography is very accurate in differentiating between 
sphincter defects and atrophy and correlates well with findings at 
surgery.15,16 The ultrasonography is also used for the detection of fistulas 
and anorectal carcinomas.16 
Pudendal nerve terminal motor latency times (PNTML) are assessed in 
our studies with a glove mounted electrode measuring the conduction of 
this nerve. In this thesis pudendopathy is defined as PNTML >2.4 ms. 
The measurement is operator dependent, and does not correlate with anal 
sphincter pressures.2 PNTML increases physiologically with age and this 
must therefore be taken in consideration.17 PNTML measures only the 
fastest conducting fibres in the pudendal nerve, with the result that a 
damaged nerve may nevertheless show a normal conduction time as long 
as some fast-conducting fibres remain.2 Pudendopathy can be caused by 
spinal cord injury,8 after prolonged straining, rectal prolapse, pelvic floor 
dysfunction, colorectal, urological or gynaecological procedures.19-22 
Defaecography is a dynamic assessment of the process, the rate and 
completeness of rectal evacuation. It is of value in diagnosing 
intussusception, enterocele, rectocele, rectal prolapse or impaired 
function of the pelvic floor.2 Additionally, it is a good technique to detect 
pelvic floor dyssynergia.10 
Sigmoidoscopy is necessary to exclude organic disease in patients with 
defaecation disorders.2 Colonic transit times are important to diagnose 
slow transit constipation of the whole colon or a segment. It is important 
to ensure normal small bowel peristalsis by antroduodenal manometry 
before a subtotal colectomy is considered.18 
In conclusion, decreased anorectal function and structure can cause 
faecal incontinence or constipation. The aetiology is usually 
multifactorial. Analysis of anorectal function and anatomy is therefore 
important to come to a more precise diagnosis to guide the treatment 
upon.  
It is clear that there is no single objective investigation considered as the 
definitive test for anorectal function.23 Anorectal manometry, rectal 
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sensitivity and capacity tests and endo-anal ultrasonography are the 
recommended anorectal function tests for patients with faecal 
incontinence. These tests have a direct clinical impact. PNTML 
measurements and defaecography can provide additional information.24  
The clinical relevance of the individual anorectal tests is not always 
evident, but the potential strength comes from combining the test 
results.25 In case of constipation anorectal manometry, rectal sensitivity 
and capacity tests are important as well as defaecography and colonic 
transit times.2 Therefore, it is important to assess the medical history of 
the patient to reveal the aetiology of the defaecation disorder. Possible 
aetiologies are mentioned in Table 9.2 separating constipation and faecal 
incontinence, however many aetiologies are overlapping.  
 
 
Table 9.2 Different aetiologies of faecal incontinence and constipation and their underlying 
disorders. 
Aetiology  Underlying disorder  
 Faecal 
incontinence 
Combination Constipation 
Congenital  Anal atresia 
Spina bifida 
M. Hirschsprung 
 
Trauma Obstetric injury 
Anal impalement 
Pelvic fracture 
Anorectal surgery 
Colorectal surgery 
Gynaecologic surgery 
Urologic surgery 
 
Pelvic outlet 
obstruction 
 Recto-anal(vaginal) 
prolapse 
Pelvic floor 
dyssynergia 
Intussusception 
Solitary rectal ulcer 
Neurologic/ 
endocrine disorder 
Hyperthyroidism Diabetes mellitus 
Multiple sclerosis 
Dementia 
Parkinson 
Myasthenia gravis 
Multiple system 
atrophy 
Spinal cord injury 
Hypothyroidism 
Functional disorder Malabsorption 
IBD 
Laxative abuse 
Psychiatric disorder 
 
 
Low residue diet 
Low fluid intake 
Slow-transit colon 
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TREATMENT OF FAECAL INCONTINENCE 
The aim of treatment of faecal incontinence is to restore continence and 
improve quality of life with minimal morbidity and mortality.23 The 
majority of patients benefit from conservative measures, like diet 
modifications, medication and pelvic floor rehabilitation (PFR). PFR has 
successful results in some patients.26 Also retrograde colonic irrigation 
(RCI) is a satisfactory treatment for many patients.27 
Surgical procedures are considered in selected patients. Anal sphincter 
repair is best suited for patients with an anterior sphincter defect. The 
short-term results are good, but in the long-term many patients have 
recurrent faecal incontinence. This is thought to be caused by breakdown 
of the sphincteroplasty in the short-term, aging, scarring and progressive 
pudendal neuropathy related to the initial injury or caused by the 
sphincter repair in the long-term.23 A test stimulation (TS) with Sacral 
Nerve Modulation (SNM) can be performed in patients with minor 
sphincter defects. The advantage of SNM that it can be tested before the 
definitive implant must be emphasized. Therefore, we advice to perform 
a TS before proceeding to other invasive treatment modalities. In case of 
failing anal repair in a disrupted sphincter, sphincter replacement 
techniques like ABS and DGP are used as the last treatment option for 
many patients, before performing an end-colostomy. Figure 9.1 shows 
the use of DGP, ABS and SNM in the Maastricht University Medical 
Centre in years, showing an increased incidence of SNM compared to 
DGP and ABS. This will probably be the trend in the future, but the DGP 
and ABS will remain necessary in a selected group of patients. 
Furthermore, the amount of patients with an ABS is increasing in 
comparison to the DGP. This is explained that the patients eligible for 
both, can choose for either DGP or ABS. In the past, only the DGP was 
available. The initial results of DGP and ABS are very good,28-30 in the 
long-term results reveal complications and deterioration in some patients 
with a high rate of onset constipation, but still 60% of these patients have 
good results in the long-term.31,32 
After failing surgery, retrograde or antegrade colonic irrigation (ACI) 
should not be forgotten before proceeding to an end-colostomy.  
Predictors of outcome for different surgical procedures for faecal 
incontinence are difficult to assess. The indications for the different 
surgical treatments are often overlapping.23 Few studies tried to define 
predictors for successful outcome of surgery. Glasgow et al. reported 
significantly improved faecal continence after perineal proctectomy for 
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rectal prolapse in patients with resting pressures >60mmHg.33 In the 
study of Dudding et al. there were no significant differences between 
patients with successful TS and unsuccessful TS in terms of preoperative 
results of anorectal manometry or rectal balloon insufflation.34 Altomare 
et al. reported in a study with 82 patients that anal sphincter 
electromyography can predict the outcome of PNE in SNM, in contrary 
to PNTML, which does not contribute to the prediction of outcome.35 
The flow sheet for recommendation of treatment of faecal incontinence is 
presented in Figure 9.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1 Percentages of SNM, ABS and DGP in years. 
TREATMENT OF CONSTIPATION 
The treatment of constipation has a lot of overlap with faecal 
incontinence. Most constipated patients have a lack of dietary fibre and 
respond to simple measures, often without a physician.36 In case of 
failing dietary modifications PFR can be successful in patients with 
pelvic floor dyssynergia.10,37 RCI is often successful in patients with 
constipation of different aetiologies.38 When these treatments are failing 
and there is no suspicion of an underlying carcinoma or IBD, colorectal 
physiology testing is performed. This can classify the constipation of 
patients which is followed by the decision for different treatments. In a 
series of 277 highly selected patients from a tertiary referral centre with 
intractable constipation only 29% had an objectivated abnormality.39 
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Figure 9.2 A schematic overview of the treatment of faecal incontinence. PFR, pelvic floor  
 rehabilitation; RCI, retrograde colonic irrigation; LAR, low anterior resection; 
SNM, sacral nerve modulation; AR, anal repair; DGP, dynamic graciloplasty; 
ABS, artificial bowel sphincter; ACI, antegrade colonic irrigation. 
 
 
SNM can be performed in case of slow transit constipation, pelvic floor 
dyssynergia, spina bifida or idiopathic constipation and RCI can be used 
in all cases, except in patients with severe rectal prolapse, rectocele, 
enterocele or intussusception. In case of slow transit constipation, a 
(sub)total colectomy can be performed in total slow transit and a 
segmental colectomy in case of a segmental slow transit.40 In case of 
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Figure 9.3 A schematic overview of the treatment of constipation. PFR, pelvic floor 
rehabilitation; RCI, retrograde colonic irrigation; SNM, sacral nerve modulation; 
ACI, antegrade colonic irrigation. 
 
 
failing RCI, and this can especially happen in patients with slow transit 
constipation, ACI can be attempted,41 but the patient has to be well 
informed about the complications. An end-colostomy is satisfying for 
some patients.42 The flow sheet for recommendation of treatment for 
constipation is presented in Figure 9.3. 
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COMPLICATIONS OF SURGICAL PROCEDURES 
A review of SNM for faecal incontinence revealed an adverse event (AE) 
rate of 0.04 per patient for the PNE and 0.12 AE per patient for the 
permanent implantation. The most serious complication was an infection 
of the implant, requiring removal in three patients.43 In this review 
wrongly placed electrodes were not mentioned. It is not clear if this was 
not recognized as an AE or not recorded.43 The AE rate of the permanent 
implantation is also high (0.12 event per patient), but lower compared to 
the DGP, ABS or end-colostomy. Constipation is a common 
complication after surgical procedures for faecal incontinence,29,31,32,44 
but until now was not reported in SNM.43,45 
Two reviews studying the complications of DGP revealed 0.82-1.1 AE 
per patient.46,47 One review of the ABS reported 1.68 AE per patient.47 In 
both reviews the most serious complication was infection of the 
implant.46,47 Another review describing AE of the end-colostomy 
reported 0.51 event per patient.46  
COSTS 
The five-year cumulative costs for conservative treatment in faecal 
incontinence is 3234 euro.48 The estimated five-years cumulative cost for 
the irrigation pump is 573 euro and for the irrigation bag 527 euro, 
additionally the catheters cost 370 euro in five years. The cost for an 
anterior anal sphincter repair is 5327 euro, but a symptomatic recurrence 
rate of up to 50% in the long-term is described. The costs for PNE and 
test stimulation are 4.053 euro. The five-years cumulative cost for a SNM 
is 22.150 euro, compared to 33.996 euro for an end-colostomy, and 
31.590 euro for a DGP.48 
The cost of an ABS and DGP is compared in another study, giving five-
years cumulative costs of an ABS of 29.740 euro.49 
PRESERVE THE UTERUS 
Many patients revealed a hysterectomy in the different studies of this 
thesis, this seems remarkable. In Chapter 2, 13 (33%) patients had a 
previous hysterectomy, in Chapter 3, 16 (46%) had undergone a 
hysterectomy and in Chapter 7, 17 (37%) patients had a medical history 
with a hysterectomy. However, 40% of females will have undergone a 
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hysterectomy at the age of 60 years in the United States.50,51 In the 
studies, the mean age of patients was 58.0 years in Chapter 2, 59.0 years 
in Chapter 3 and 59.3 years in Chapter 7, so the ages of the patients 
correlate well with the rate of hysterectomy in these studies.  
The prospective study of Mann et al. compares 382 patients awaiting 
hysterectomy with 130 healthy controls. Women awaiting hysterectomy 
reported abnormal urinary symptoms and more faecal incontinence than 
the age-matched group.52 A prospective study of Forsgren et al. reported 
a group of 120 patients undergoing hysterectomy for benign conditions. 
Symptoms of faecal incontinence increased significantly one year after 
abdominal hysterectomy and three years after vaginal hysterectomy. A 
reported history of obstetric sphincter injury and increasing age were 
correlated to an increased risk of developing post-hysterectomy faecal 
incontinence. Concomitant bilateral salpingo-oopherectomy with the 
abdominal hysterectomy was a risk factor for faecal incontinence at a 
follow-up of one year, but this was not present at a follow-up of three 
years.53 Abdominal hysterectomy was also a risk factor for developing 
faecal incontinence which was further increased by concomitant bilateral 
salpingo-oopherectomy in a study including 120 patients with benign 
conditions of the uterus with a follow-up of one year.54 There were no 
statistically significant changes in urinary or bowel symptoms before and 
after abdominal hysterectomy in 43 women for benign gynaecologic 
conditions. The preoperative symptoms resolved in some women after 
surgery and developed in others. New laxative use was reported after 
hysterectomy.55 
The complaints after hysterectomy are most probably caused by nerve 
damage after hysterectomy and/or prolapse after hysterectomy. The 
bilateral inferior hypogastric plexus provide (para)sympathetic 
innervations to the lower pelvic viscera and are located in close 
proximity to the proximal vagina and distal rectum. The pelvic floor and 
anal sphincters are innervated by the pudendal nerve. Hysterectomy 
involves dissection of the paracervical tissues in close proximity to the 
hypogastric plexus, probably causing damage to these nerve fibres.56  
In conclusion, defaecation disorders can improve, worsen or develop 
after hysterectomy. Preservation of de uterus should be considered in 
every patient referred to the gynaecologist for benign and malign 
disorders of the uterus. 
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SUMMARY 
The aim of this thesis was to investigate different conservative and 
surgical treatment modalities for defaecation disorders.  
Colonic irrigation for the treatment of defaecation disorders can be 
considered after failing diet modifications or medication, but also after 
failed surgical treatment. Chapter 2 describes the success and pitfalls of 
retrograde colonic irrigation (RCI) in patients with defaecation disorders 
in a prospective study. The 39 patients with a mean age of 58.0±13.5 
years included in this prospective study were divided into three groups: 
patients with faecal incontinence (group A), patients with constipation 
(group B) and patients with a combination of faecal incontinence and 
constipation (group C). The Biotrol® Irrimatic pump (Braun®) and the 
irrigation bag (Braun®) were used for colonic irrigation. At a follow-up 
of three months, 59% of the patients of group A (n=18) were 
(pseudo)continent for faeces (P<0.001). The Parks’ score reduced for all 
incontinent patients from group A at three months, six months and one 
year (P=0.0005, P =0.036, P =0.005). In 20% of the patients of group B 
(n=11) the feeling of incomplete evacuation, straining and bloating 
disappeared (P=0.007, P=0.051 and P=0.055). The overall quality of life 
score improved significantly (P=0.012).  
Pelvic floor rehabilitation (PFR), another conservative treatment, can be 
successful in some patients. However, when PFR and other conservative 
treatments are failing, anorectal investigations can be performed to reveal 
the possible aetiology of the defaecation disorders. Sacral nerve 
modulation (SNM) is a minimal invasive technique for the treatment of 
defaecation disorders, and also the only surgical procedure that can be 
tested before the definitive surgical procedure. In Chapter 3 the results 
of SNM after negative outcome of PFR for the treatment of faecal 
incontinence are investigated in a prospective multicentre cohort study. 
Thirty-five patients with a mean age of 59.7±11.4 years were included: 
21 had a successful test stimulation (TS) and 19 patients proceeded to a 
SNM implant. Incontinence decreased significantly during TS and SNM 
for a mean of 24.1 months follow-up (P<0.001). The overall success rate 
was 49% (17/35). The 18 patients with unsuccessful TS or SNM received 
other treatments (OT). The Vaizey score improved in both SNM 
(P=0.004) and OT (P=0.019). The disease specific quality of life scale 
(HAQL scale) improved significantly during SNM in all subscales 
(P<0.008), but not in the OT group. Eight adverse events (AE) occurred 
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during TS (0.24 AE per patient) and six AE after permanent implantation 
(0.32 AE per patient).  
The exact working mechanism of SNM is still unclear. A placebo effect 
is excluded when a therapeutic effect can be induced below the 
sensitivity threshold. It also implies that the working mechanism of SNM 
is not (only) a direct motoric effect on the anal sphincter, but more likely 
a modulating effect on the neural network. Chapter 4 describes eight 
patients with a median age of 58.5 (32.5-66.6) years with faecal 
incontinence and successful implantation with SNM with a median 
follow-up of 6.3 months. The sensitivity threshold (ST) (patients feels the 
stimulation) and motor threshold (MT) (anal sphincter response on 
stimulation) were determined. The patients went home with a voltage of 
0.6 Volts below the ST. Every week the voltage was increased with 0.2 
Volts until the ST was reached. In this way the suboptimal (STT) and 
optimal therapeutic response threshold (TT) could be determined. The 
TT (median 1.6 Volts) was significantly lower than the sensitivity 
threshold (median 1.7 Volts) (P =0.042). The median MT was 2.1 Volts 
and significantly higher than the ST (P=0.009). The STT was 1.4 Volts. 
In five of eight patients the TT was the same as the ST. 
Faecal incontinence, constipation, urinary incontinence and retention, are 
major impairments affecting the quality of life and social integration of 
patients with spina bifida (SB). Chapter 5 assesses SNM in patients with 
SB for the treatment of defaecation and voiding disorders. Ten patients 
were included in this study with a median age of 26.4 (11.1-41.0) years. 
In two patients the peripheral nerve evaluation (PNE) was unsuccessful 
and consequently eight patients underwent a TS. The median 
incontinence days and episodes per 21 days decreased significantly 
during TS (P=0.033), but only three of ten (30%) patients had a more 
than 50% improvement and proceeded to SNM implantation. All patients 
had a malformed sacrum. Patients with absent pudendal nerve terminal 
motor latency times (PNMTL) were technically more difficult to 
stimulate, but successful PNE and/or TS was not excluded in these 
patients. 
Patients born with an anorectal malformation (ARM) have usually a 
surgical correction at a young age. Nevertheless, some of these patients 
suffer from faecal incontinence in later life resulting in a severely 
impaired quality of life. In patients suffering from faecal incontinence, 
with failing anal sphincters, a sphincter replacing operation can be 
performed: a dynamic graciloplasty (DGP) or an artificial bowel 
sphincter (ABS). A DGP is a surgical treatment modality offering an 
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opportunity for independence and autonomy in patients with an ARM. 
Chapter 6 assesses the long-term results of patients born with an ARM 
and faecal incontinence treated with DGP. Twenty-eight patients were 
included with a median age of 25.5 (12.4-49.1) years and a median 
follow-up of 4.0 years. A high ARM was present in 25/28 (89.3%) 
patients. Conventional graciloplasty was already performed in ten of 28 
(36%). All patients were incontinent for faeces (Grade 4 or 5 in 
Williams’ continence score). Continence for faeces was reached in 35% 
of the patients, 29% was incontinent for liquid stool and 36% was still 
incontinent for solid stool. Satisfactory continence was only achieved in 
18% of the patients with a high ARM, compared to 100% of the patients 
with a low ARM. Patients with a successful DGP demonstrated a higher 
preoperative rectal capacity compared to patients with a failed DGP (236 
versus 163 ml, P<0.180). The median postponement time improved 
significantly from 0 (0-5) to 2 minutes (0-60)(P=0.001). Complications 
were noted in 53% of the patients. Explantation of the DGP was 
necessary in nine of 28 (32%) of the patients, mainly due to infection of 
the implant. 
Colonic irrigation can be used after all failing surgical procedures. 
Chapter 7 reports the success of colonic irrigation as an additional or 
salvage treatment for defaecation disorders after unsuccessful or partially 
successful DGP in a cross-sectional study. The 46 patients who were 
included were asked to fill out a detailed questionnaire about colonic 
irrigation. The patients had a mean age of 59.3±12.4 years. On average, 
the patients started the RCI 21.4±38.8 months after DGP. Eight patients 
started RCI before the DGP. Fifty-two percent of the patients used the 
RCI as additional therapy for faecal incontinence, 24% for constipation 
and 24% for both. Overall, 81% of the patients were satisfied with the 
RCI. Thirty-seven percent of the patients with faecal incontinence 
reached (pseudo)continence and in 30% of the patients the constipation 
completely resolved. Side-effects of the RCI were reported in 61% of the 
patients: leakage of water after irrigation, abdominal cramps and 
abdominal bloating. Seven (15%) patients stopped the RCI. 
Chapter 8 evaluates the results of RCI in patients with faecal 
incontinence after a Low Anterior Resection for rectal carcinoma. Thirty 
patients were selected and 26 patients were available for the study. Data 
were gathered by chart research and a telephone interview with a 
questionnaire. Five patients stopped with the treatment due to side-
effects. Twelve of the 21 (57%) patients who still performed RCI became 
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completely (pseudo) continent, three (14%) patients were incontinent for 
flatus and six (29%) patients were still incontinent for liquid stool.  
CONCLUSIONS 
1. RCI is an undervalued but effective alternative for the treatment of 
intractable defaecation disorders as primary conservative treatment, 
but also after failing surgical treatment or side-effects like onset 
constipation after surgical treatment for faecal incontinence. RCI is 
minimal invasive and has only mild side-effects. 
 
2. SNM is successful in about half of the patients with faecal 
incontinence after unsuccessful standardized PFR. SNM improves 
disease specific quality of life significantly compared to OT. 
 
3. It is possible to have a therapeutic effect of SNM below the ST. This 
excludes a placebo effect of SNM. A lower stimulation voltage 
means a longer longevity of the pulse generator.   
 
4. SNM can be successful in a subgroup of SB patients with combined 
defaecation and voiding functional disorders. A malformed sacrum or 
an absent PNMTL does not exclude a successful SNM. 
 
5. Results of DGP for faecal incontinence are reasonable for patients 
with ARM. Rectal function and type of malformation are prognostic 
factors for outcome and can be used to select the patients for DGP 
treatment, thereby improving the results. 
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SAMENVATTING 
De studies in deze thesis betreffen verschillende conservatieve en 
chirurgische behandelingsmogelijkheden van defecatiestoornissen: fecale 
incontinentie en obstipatie. 
Na falende dieetmaatregelen en medicamenteuze behandeling, kan 
retrograde colon irrigatie (RCI) worden overwogen voor de behandeling 
van defecatiestoornissen, maar RCI is ook een optie na falende 
chirurgische behandeling. Hoofdstuk 2 beschrijft het succes en de 
neveneffecten van RCI bij 39 patiënten met defecatiestoornissen in een 
prospectieve studie (gem. lftd 58.0±13.5 jaar). De patiënten werden 
verdeeld in drie groepen: patiënten met fecale incontinentie (groep A), 
obstipatie (groep B) of gecombineerde fecale incontinentie of obstipatie 
(groep C). De Biotrol® Irrimatic spoelpomp (Braun®) en de irrigatie zak 
(Braun®) werden gebruikt voor RCI. Bij een follow-up van 3 maanden 
waren 59% van de patiënten uit groep A (n=18) (pseudo)continent voor 
ontlasting (P<0.001). De Parks’ score (1-4) verbeterde voor alle patiënten 
in groep A bij 3, 6 en 12 maanden (P<0.001, P=0.036, P=0.005). In 20% 
van de patiënten van groep B (n=11) verdween het gevoel van 
onvolledige evacuatie, persen en opgeblazen gevoel (P=0.007, P=0.051 
and P=0.055) De totale kwaliteit van leven score verbeterde significant 
(P=0.012).  
Biofeedbacktherapie (PFR), een andere conservatieve behandeling is 
succesvol voor sommige patiënten. Bij falen van de PFR en andere 
conservatieve behandelingen, kunnen anorectale onderzoeken worden 
uitgevoerd om de mogelijke etiologie van de defecatiestoornis te 
achterhalen. Sacrale neuromodulatie (SNM) is een minimaal invasieve 
techniek om defecatiestoornissen te behandelen. Daarnaast is het ook de 
enige chirurgische techniek die een proefbehandeling kent, voordat de 
definitieve chirurgische procedure wordt uitgevoerd. In Hoofdstuk 3 
worden de resultaten van SNM na het falen van een gestandaardiseerd 
PFR programma voor de behandeling van fecale incontinentie 
onderzocht in een prospectieve multicenter cohort studie. 35 Patiënten 
met een gemiddelde leeftijd van 59.7±11.4 jaar werden geïncludeerd: 21 
patiënten hadden een succesvolle teststimulatie (TS) en 19 patiënten 
werden geïmplanteerd met SNM. Fecale incontinentie verbeterde 
significant gedurende TS en SNM gedurende een gemiddelde follow-up 
van 24.1 maanden (P<0.001). Het totale succespercentage was 49% 
(17/35). De 18 patiënten zonder succesvolle TS of SNM kregen andere 
behandelingen (OT). De Vaizey score verbeterde gedurende SNM 
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(P=0.004) en OT (P=0.019). De ziektespecifieke kwaliteit van leven 
score (HAQL) verbeterde significant gedurende SNM in alle subscores 
(P<0.008), echter niet tijdens OT. Er traden acht complicaties op 
gedurende TS (0.24 complicatie per patiënt) en zes complicaties na 
permanente implantatie met SNM (0.32 complicatie per patiënt).  
Het precieze werkingsmechanisme van SNM is nog steeds onduidelijk. 
Een placebo-effect kan uitgesloten worden wanneer een therapeutisch 
effect kan worden geïnduceerd bij een stimulatievoltage lager dan de 
drempel waarbij de patiënt de stimulatie waarneemt 
(sensitiviteitsdrempel). Het impliceert dat het werkingsmechanisme van 
SNM niet of nauwelijks wordt bepaald door een direct motorisch effect 
op de anale sfincter, maar door een modulerend effect op het neurale 
netwerk. Hoofdstuk 4 beschrijft acht patiënten met een mediane leeftijd 
van 58.5 (32.5-66.6) jaar, die succesvol behandeld waren voor fecale 
incontinentie met een SNM implantatie gedurende een mediane follow-
up van 6.3 maanden. De sensitiviteitsdrempel (ST) en motorische 
drempel (MT) (anale sfincter respons op stimulatie) werden bepaald. De 
patiënten gingen naar huis met een voltage 0.6 Volt lager dan de ST. Elke 
week werd het voltage verhoogd met 0.2 Volt totdat de ST werd bereikt. 
Op deze manier konden ook de suboptimale (STT) en optimale 
therapeutische responsdrempel (TT) worden bepaald. De TT (mediaan 
1.6 Volt) was significant lager dan de ST (mediaan 1.7 Volts) (P=0.042). 
De mediane MT was 2.1 Volt en significant hoger dan de ST (P=0.009). 
De STT was 1.4 Volt. In vijf van de acht patiënten was de TT gelijk aan 
de ST. 
Fecale incontinentie, obstipatie, urine incontinentie en retentie, zijn 
ziektebeelden die de kwaliteit van leven en sociale integratie van 
patiënten met spina bifida (SB) verslechteren. In Hoofdstuk 5 wordt het 
resultaat van SNM in patiënten met SB voor de behandeling van hun 
defecatiestoornissen en mictiestoornissen onderzocht. Tien patiënten 
werden geïncludeerd in deze studie met een mediane leeftijd van 26.4 
(range 11.1-41.0) jaar. In twee patiënten was de perifere neurale evaluatie 
(PNE) niet mogelijk en dus kregen acht patiënten een TS. De mediane 
incontinentiedagen en episodes per 21 dagen verbeterden significant 
gedurende TS (P=0.033), echter slechts drie van tien (30%) patiënten had 
een verbetering van meer dan 50% en kregen een SNM implantatie. Alle 
patiënten hadden een afwijkend sacrum. Patiënten met een afwezige 
nervus pudendus geleidingstijd (PNMTL) waren technisch moeilijker te 
stimuleren, maar een succesvolle PNE en/of TS was niet uitgesloten in 
deze patiëntengroep. 
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Patiënten geboren met een anorectale malformatie (ARM), worden 
meestal op jonge leeftijd geopereerd. Toch hebben sommige patiënten 
fecale incontinentie in hun latere leven wat resulteert in een ernstige 
verslechtering van de kwaliteit van leven. Bij patiënten met een falende, 
defecte anale sfincter kan een sfincter-vervangende operatie worden 
uitgevoerd: Dynamische gracilisplastiek (DGP) of een artificial bowel 
sphincter implantatie. Een DGP is een chirurgische behandeling die 
patiënten met een ARM een mogelijkheid geeft tot onafhankelijkheid en 
autonomie. In Hoofdstuk 6 worden de lange termijn resultaten 
bestudeerd van patiënten geboren met een ARM en fecale incontinentie, 
die behandeld waren met een DGP. 28 Patiënten werden geïncludeerd 
met een mediane leeftijd van 25.5 jaar en een mediane follow-up van 4.0 
jaar. Een hoge ARM was aanwezig in 25/28 (89.3%) patiënten. 
Continentie voor ontlasting werd bereikt in 35% van de patiënten, 29% 
van de patiënten waren incontinent voor diarree en 36% van de patiënten 
waren nog incontinent voor vaste ontlasting. De continentie was naar 
tevredenheid in slechts 18% van de patiënten met een hoge ARM, in 
vergelijking met 100% van de patiënten met een lage ARM. Patiënten 
met een succesvolle DGP hadden een hogere preoperatieve rectale 
capaciteit in vergelijking met patiënten met een slecht resultaat van de 
DGP (236 versus 163 ml, P<0.180). De mediane tijd voor het uitstellen 
van de ontlasting verbeterde significant van 0 (0-5) tot twee minuten (0-
60). Complicaties waren aanwezig in 53% van de patiënten. Explantatie 
van de DGP was vereist in 32% van de patiënten, meestal als gevolg van 
infectie van het implantaat. 
Colon irrigatie kan worden toegepast na alle falende chirurgische 
procedures. Hoofdstuk 7 rapporteert het succes van colon irrigatie als 
een additionele behandeling voor defecatiestoornissen na niet of 
onvoldoende succesvolle DGP in een cross-sectionele studie. De 46 
geïncludeerde patiënten werden gevraagd om een gedetailleerde 
vragenlijst in te vullen over het gebruik van colon irrigatie. De patiënten 
hadden een gemiddelde leeftijd van 59.3±12.4 jaar. De patiënten startten 
de irrigatie gemiddeld 21.39±38.77 maanden na de DGP. Acht patiënten 
startten de irrigatie vóór de DGP. Tweeënvijftig procent van de patiënten 
gebruikten de irrigatie als additionele therapie voor fecale incontinentie, 
24% voor obstipatie en 24% voor beiden. In totaal waren 81% van de 
patiënten tevreden met de irrigatie. (Pseudo)continentie werd bereikt in 
37% van de patiënten met fecale incontinentie en in 30% van de 
patiënten verdwenen de klachten van obstipatie volledig. Neveneffecten 
van de irrigatie waren aanwezig in 61% van de patiënten: lekkage van 
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water na de irrigatie, buikkrampen en een opgeblazen buik. Zeven (15%) 
patiënten stopten met irrigeren. 
Hoofdstuk 8 evalueert de resultaten van RCI in patiënten met fecale 
incontinentie na een Low Anterior Resectie voor een rectumcarcinoom. 
Dertig patiënten werden geselecteerd, waarvan 26 patiënten beschikbaar 
waren voor de studie. Data werden verzameld door dossieronderzoek en 
een telefonisch interview met vragenlijst. Vijf patiënten stopten met de 
irrigatie vanwege neveneffecten. Twaalf van de 21 (57%) patiënten die 
de RCI continueerden werden volledig (pseudo)continent, drie (14%) 
patiënten waren incontinent voor flatus en zes (29%) patiënten waren nog 
incontinent voor diarree.  
CONCLUSIES 
1. RCI is een ondergewaardeerd, maar effectief alternatief voor de 
behandeling van onbehandelbare defecatiestoornissen als primaire 
conservatieve behandeling. Echter ook na falende chirurgische 
behandeling voor fecale incontinentie of neveneffecten zoals 
obstipatie na een behandeling voor fecale incontinentie. RCI is 
minimaal invasief en heeft slechts milde neveneffecten. 
 
2. SNM is succesvol in ongeveer de helft van de patiënten met fecale 
incontinentie na falende gestandaardiseerde PFR. SNM verbetert 
ziektespecifieke kwaliteit van leven significant in vergelijking met 
andere behandelingen. 
 
3. Het is mogelijk een therapeutisch effect van SNM te realiseren onder 
de sensitiviteitsdrempel. Dit sluit een placebo-effect van SNM vrijwel 
uit. Een lager stimulatie voltage betekent een langere levensduur van 
de pacemaker.  
 
4. SNM kan succesvol zijn in een subgroep van SB patiënten met 
gecombineerde functionele defecatie- en mictiestoornissen. Een 
afwijkend sacrum of afwezige PNMTL sluit een succesvolle SNM 
niet uit. 
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5. Resultaten van DGP voor fecale incontinentie zijn redelijk voor 
patiënten met een ARM. Rectale functie and type malformatie zijn 
prognostische factoren voor resultaat en kunnen gebruikt worden om 
patiënten voor een behandeling met DGP te selecteren, waardoor de 
resultaten verbeteren. 
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LIST OF ABBREVIATIONS 
ABS Artificial Bowel Sphincter 
ASCRS questionnaire American Society of Colon and Rectal Surgery 
quality of life questionnaire 
ARM  Anorectal Malformation 
DGP   Dynamic Graciloplasty 
EQ-5D  EuroQol quality of life questionnaire  
FRSV   First rectal sensation volume  
FUSV   First urge sensation volume  
HAQL  Hirschsprung's disease/anorectal malformation 
quality of life 
IPG   Implantable pulse generator  
MACE  Malone Antegrade Colonic Enema 
MT Motor Threshold  
MTV   Maximal tolerated volume  
OT  Other Treatment 
PFR  Pelvic Floor Rehabilitation 
PNE  Peripheral Nerve Evaluation 
PNTML   Pudendal Nerve Terminal Motor Latency Times 
RAIR   Recto-anal inhibitory reflex  
RCI  Retrograde Colonic Irrigation 
SB  Spina bifida 
SF-36  Short Form 36 health survey 
SNM   Sacral Nerve Modulation 
ST Sensitivity Threshold  
STT Suboptimal Therapeutic response Threshold  
TS  Test stimulation 
TT  Therapeutic response Threshold 
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